New membrane technologies for dialysis by Lu, Limin




presented to the University of Waterloo
in fulfillment of the




Waterloo, Ontario, Canada, 2016
c© Limin Lu 2016
Author’s Declaration
This thesis consists of material all of which I authored or co-authored: see State-
ment of Contributions included in the thesis. This is a true copy of the thesis,
including any required final revisions, as accepted by my examiners. I understand
that my thesis may be made electronically available to the public.
ii
Statement of Contributions
I hereby declare that I have contributed to the majority of research work in
this thesis wherein Chapters 4 and 5 include published articles.
My contributions to this thesis include design, development, characterization,
testing and analysis of zeolite incorporated polymer membranes that can adsorb
uremic toxins. Full citation of the articles along with the corresponding chapters
is as follows:
Lu L, Samarasekera C., Yeow J.T. Creatinine adsorption capacity of electrospun polyacry-
lonitrile (PAN)-zeolite nanofiber membranes for potential artificial kidney applications. Journal
of Applied Polymer Science. 2015. [Chapter 4]
Lu L., Chen C., Samarasekera C, Yeow J.T.W. Influence of zeolite shape and particle size
on their capacity to adsorb uremic toxin as powders and as fillers in membranes. Journal of
Biomedical Materials Research Part B: Applied Biomaterials. 2016. [Chapter 5]
iii
Abstract
Hemodialysis, developed in 1960s, has served as a treatment for patients with
end stage renal disease. However, the 5 year mortality rate of hemodialysis pa-
tients is 65%. Research shows that some protein-bound toxins, which cannot to
be cleared by hemodialysis, play an important role in mortality of hemodialysis
patients. In order to improve the mortality rate of hemodialysis patients, we cre-
ated a new type of hemodialysis membranes, which can remove more toxins than
current hemodialysis membranes.
In this thesis, we first adopted electrospinning technology to synthesis hemodial-
ysis membranes with adsorptive nanoparticles. Polyacrylonitrile-zeolite nanofiber
composite membranes were fabricated and their ability to adsorb water soluble
uremic toxins was tested. The results show that both the free zeolite powder and
membranes with zeolite can adsorb creatinine at high level and fast speed. The
creatinine adsorption level of 940-zeolite powders is 25423 µg g−1 in 625 µmol L−1
creatinine solution. 0.025 g of 940-zeolite powders can eliminate 91% of 2 µmol
creatinine in 5 min.
In order to choose good zeolites, we also carried out experiments to study how
their size and shape influence the creatinine uptake level. Spherical micro-particle
840, spherical nanoparticle P-87 and rod-like nanoparticle P-371 zeolites were
tested. Experiments show that the zeolites have similar creatinine uptake ability
as powders. However, they have significantly different creatinine uptake ability
after being incorporated inside the membranes. Micro-particle and sphere-shaped
particles perform better inside the membranes.
Although the membranes we fabricated through electrospinning can adsorb
water soluble toxins, their pore size is too large for hemodialysis. In another part
of the thesis, we used spin-coating technologies to synthesize polyethersulphone
iv
zeolite composite membranes with suitable pore size. Experiments showed that
these membranes can adsorb 4948 µg creatinine per g membranes. The effects of
pH and salt on zeolite’s adsorption and desorption of creatinine were also studied
in order to infer the membrane’s adsorption mechanism. We found that acidic
environments enhance zeolite’s creatinine adsorption while alkaline environments
weaken it. The existence of various cations also decreases zeolite’s creatinine
adsorption.
Finally, we tested the adsorption of protein-bound toxin by our membranes.
Studies have shown that these toxins are related to the progression of chronic
kidney disease (CKD), and to the generation and aggravation of cardiovascular
disease. Indoxyl sulfate, an important toxin in causing reno-cardiovascular syn-
dromes, was chosen as a representative of protein-bound toxins. Experiments
show that zeolite-PES membranes can adsorb 550 µg indoxyl sulfate per g mem-
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Kidney failure is a widespread condition that affects millions of people. Worldwide, over
2 million people currently receive renal replacement treatment to stay alive, and this
number likely represents less than 10% of those who need it. Kidney failure patients
accounted for more than 661,000 in the US in 2015 [1]. In Canada, the number of people
with kidney disease has more than doubled in the last 20 years. It is estimated that as
many as one in ten Canadians have kidney disease, and millions more are at risk. Each
day, an average of 15 people are told that their kidneys have failed.
When a patient’s kidneys fail to clear waste from the body, hemodialysis is the
major medical treatment to keep the patient alive. Hemodialysis is the process of
removing waste and excess water from the blood to dialyzate through semi-permeable
membranes. In US, 71% of patients with kidney failure are on traditional hemodialysis.
In Canada, among all the 41,252 people being treated for kidney failure, 58% of them
are on traditional hemodialysis.
The cost and the mortality rate of hemodialysis are high. On average, it costs
$83,356 per patient per year for hemodialysis treatment. For end stage renal hemodial-
ysis, the mortality rate of these patients is 20-25% after one year on hemodialysis and
the 5-year mortality rate is 65% [1].
Furthermore, current hemodialysis, which depends on diffusion and convection for
solute clearance through a low-flux or high-flux dialyzer, is not effective at clearing some
important toxins that play an important role in the mortality rate. Although small and
water-soluble toxins such as urea (66-75% reduction) and creatinine (66%) are readily
cleared, potential uremic toxins including indoxyl sulphate (35%), 3 cardoxy4-methyl-
5-propyl-2furanoproprionic acid (32%) and p-cresol (29%) [2], as well as middle sized
toxins such as β2 microglobulin (0.7-6.8%) [3] are cleared to a lesser extent. Davenport’s
studies [4, 2] showed that short-term survival (measured in days) and medium-term
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survival (measured in months) crucially depends on a minimum removal of small molec-
ular weight water-soluble toxins, and long-term (years and decades) survival requires
improved elimination of protein-bound and middle-sized molecules [3]. Recently, phos-
phate, 2 microglobulin, indoxyl sulfate and p-cresol have been reported to be related
to an increased risk of mortality in hemodialysis patients [5]. Eknoyan [3] undertook
a five year randomized clinical study among 1846 patients undergoing thrice weekly
hemodialysis, and showed that no mortality and morbidity benefits were gained from a
higher hemodialysis dose or from using high-flux membranes in short term hemodialy-
sis. The study suggested a benefit of high-flux membranes for patients who had been
undergoing hemodialysis for more than 3.7 years.
In this thesis, we propose a membrane that can better clear uremic toxins when
compared to traditional hemodialysis membranes. This membrane is able to clear water-
soluble toxins as well as protein-bound toxins, therefore it has potential to reduce reno-
cardiovascular syndrome as well as to reduce the mortality of patients who undergo
long-term hemodialysis. The membrane is also able to eliminate the toxins very fast,
having potential to reduce the hemodialysis time needed in each section (currently, 3-4
hours). Besides diffusion and convection, the conventional filtering mechanisms, this
membrane can also eliminate toxins through adsorption.
A potentially feasible method to achieve all these purposes is to fabricate composite
hemodialysis membranes with nanoparticles. Although Tijink [6] explored composite
membranes with active carbon, the non-selective adsorbing properties of carbon adsorbs
both toxins and biological molecules.
In order to fabricate membranes that can specifically adsorb uremic toxins, first we
find adsorbents that can specifically adsorb them. Then, we incorporate them into them
into the membranes through electrospinning and spin-coating technologies. Finally, we
test the membranes’ ability to eliminate toxins and we infer the adsorption mechanism.
The thesis has been broadly organized as follows: In Chapter 2, we present some gen-
eral knowledge about kidney disease, hemodialysis, and the principles used in hemodial-
ysis. We also present the theories related to electrospinning and spin-coating, the fab-
rication methods used in this thesis.
In Chapter 3, we do a literature review on renal medical treatments that involve
adsorption mechanisms to eliminate toxins such as hemoperfusion and wearable kid-
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ney. Among all the synthesized hemodialysis membranes, we choose polyacrylonitrile
and polyethersulfone as polymer representatives, so their usage in hemodialysis is also
reviewed.
In Chapter 4 and 5, we fabricate polyacrylonitrile and zeolite membranes through
electrospinning and we test the membranes’ creatinine adsorption level. We also study
the the effect of particle size and shape on creatinine adsorption.
In Chapter 6 and 7, we fabricate polyethersulfone and zeolite membranes through
spin-coating and we test these membranes to adsorb creatinine and indoxyl sulfate. We
also study the adsorbing mechanism of zeolite.






In this chapter, general background knowledge about kidneys, hemodialysis, membranes
and uremic toxins are introduced. We also introduce electrospinning and spin-coating,
which are methods to synthesize hemodialysis membranes. Since our membranes use
zeolites as adsorbent, we also discuss the structure of zeolites.
2.1 Kidneys and medical treatments
Kidneys play an important role in maintaining human health. They sustain the equilib-
rium of water and minerals, clear acidic metabolism waste and function as part of the
endocrine system. However, when kidneys fail to clear waste products from the body,
medical treatments are needed to keep the patients alive. The most common form of
treatment is hemodialysis. Most patients spend some time on hemodialysis before a
donated kidney becomes available.
2.1.1 Kidneys
Kidneys are bean-shaped organs about 11 cm in length, 5–6 cm wide, and 3–4 cm thick.
Each kidney weighs 120–160 g [7]. The function of a normal kidney involve removal
of waste products, regulation the blood volume, blood pressure and blood’s acid-base
balance, adjustment of sodium and potassium level besides endocrinal functions.
2.1.2 Kidney failure
Kidney failure is the partial or complete loss of normal kidney functions. This is char-
acterized by the inability to remove excess water and metabolic waste from the body.
This subsequently has effects on blood pressure, blood volume and blood content. Re-
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nal failure is classified into acute kidney injury (AKI) and chronic renal failure (CRF),
depending on the cause.
The definition of AKI is “an abrupt (within 48 hours) reduction in kidney function
currently defined as an absolute increase in serum creatinine of more than or equal to
0.3 mg/dL (≥ 26.4 µmol/L), a percentage increase in serum creatinine of more than
or equal to 50% (1.5-fold from baseline), or a reduction in urine output (documented
oliguria of less than 0.5 mL/kg per hour for more than six hours)”[8].
CRF is defined by the National Kidney Foundation as either kidney damage or a
glomerular filtration rate below 60 mL/min/1.73 m2 body surface area for at least three
months.
2.1.3 Medical treatments
There are two options for treatment when a kidney fails. The most common form of
treatment is hemodialysis. The other treatment option is kidney transplantation, but
donor kidneys are limited. hemodialysis is performed as a “bridge to transplant” for
patients because it sustains their life before a donor kidney becomes available.
2.2 Hemodialysis, membranes and principles
Hemodialysis is the process of removing waste and excess water from the blood, and
is used primarily as an artificial replacement for patients with renal failure. Figure
2.1 illustrates a hemodialysis process. In hemodialysis, the patient’s blood is pumped
to the blood compartment of a dialyzer, which consists of a bundle of semi-permeable
hollow fiber membranes. When the blood flows inside the hollow fiber, the dialyzate
flows in the space surrounding the hollow fibers. Thus the excess wastes from the blood
goes to the dialyzate through diffusion and convection. Then, cleaned blood is returned
to the patient. In this process, the membrane is the most important part, since the
pore size of the membranes decides which molecules can pass through the membranes.
Dialysate is the solution in this process to pull toxins from blood. It normally consists
of pure water, sodium chloride, sodium bicarbonate or sodium acetate, calcium chloride,
potassium chloride and magnesium chloride.
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Figure 2.1: Illustration of a hemodialysis process (YassineMrabet/CC-BY-3.0).
2.2.1 Commonly used hemodialysis membranes
A hemodialysis membrane is a semipermeable membrane used to separate blood from
dialyzate during hemodialysis. The pore size of the membrane determines the selec-
tive permeability of the molecules. In addition, it affects the biological response of the
patients during and after the hemodialysis process. Commonly available hemodialy-
sis membranes can be classified into three groups: regenerated cellulose, substituted
cellulose and synthesized polymers (Table 2.1).
Cellulose
Cellulose membranes were one of the most commonly used membranes in 1960s since
they are cheap to produce and they have uniform porosity and minimal thickness[9].
They are hydrophilic due to large amount of free hydroxyl groups on the cellulose
monomers. Their disadvantages include being immunoreactive [10, 11] and only being
available in low-flux form, so they have been gradually replaced by substituted cellulose
and synthetic membranes.
Substituted cellulose
Substituted cellulose membranes are similar to cellulose membranes, but the free surface
hydroxyl groups are substituted by acetyl residuals from acetate or triacetate [12, 13, 14].
Vitamin E [15] and polyethylene glycol grafted [16] cellulose membranes have also been
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Table 2.1: Commonly available hemodialysis membranes.
Regenerated cellulose Substituted cellulose Synthetic polymers




Vitamin E coated Polyethersulfone
...
developed in order to improve the biocompatibility of cellulose membranes. In general,
the substituted cellulose membranes have better bio-compatibility. The disadvantage of
this group of membranes is that they still have low permeability for large solutes.
Synthetic membranes
Various synthetic membranes appearing since 1970s include membranes made from AN
69, polysulfone (PS), polyamide (PA), polyacrylonitrile (PAN), polymethylmethacry-
late (PMMA), polyethersulfone (PES) and polycarbonate. They are collectively known
as synthetic membranes. These polymer membranes can be manufactured with various
pore sizes and desirable molecular weight cut-off, as well as high-flux ability. These
membranes can also offer excellent biocompatibility. These membranes are mainly hy-
drophobic which can cause adsorption of cells and proteins onto the membrane surfaces.
2.2.2 Potential new hemodialysis membranes
Researchers are exploring other potentials materials for hemodialysis besides polymeric
hollow fiber membranes, including silicon, alumina and composite membranes.
Silicon membranes
The kidney project, led by Shuvo Roy andWilliam H. Fissell, dedicates to the fabrication
of an implantable artificial kidney by using silicon nano-pore membranes [17]. The
membrane used in their research has 10 nm by 45 µm slit pore arrays uniformly spaced
with 2 µm separation across a 100 mm-diameter wafer, with thickness about 4 µm
[18]. The membrane is made by surface micro-machining and micro-fabrication method.
Johnson [19] incorporated a 30 nm thick silicon membrane made by Simpore Inc. into
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Figure 2.2: Lab-on-a-chip for urea clearance by using silicon membrane. Reprinted from [19],
Copyright(2013), with permission from Elsevier.
Figure 2.3: Alumina membrane as a dialyzer. Reprinted from [20], Copyright(2009), with
permission from Wolters Kluwer Health, Inc.
micro-dialysis chip as a wearable dialyzer, as shown in Figure 2.2.
Alumina membranes
Attaluri [20] tested nanoporous alumina tubular membranes made from anodization for
hemodialysis (Figure 2.3). He concluded that alumina membranes had better hemodial-
ysis performance compared with PES membranes. However there have been no further
hemodialysis research using alumina membranes.
Composite membranes
Composite membranes were proposed by Tijink[21]. She made composite membranes by
loading activated carbon into a PES/PVP polymer blend in order to combine diffusion
and adsorption of uremic toxin solutes in one step. This idea was novel and achieved
a better uremic toxin clearance. The disadvantage of this composite membrane is that
9
Figure 2.4: Illustration of diffusion, osmosis and ultrafiltration process.
the adsorbent is carbon, which adsorbs both toxins and biological molecules.
2.2.3 Basic principles of hemodialysis
Hemodialysis is a treatment which removes excessive uremic toxins and balance blood
electrolyte components by the interchange between patient’s blood and dialyzate, across
semi-permeable membranes. The transport mechanism in current hemodialysis is mainly
diffusion and convection. Osmosis, ultrafiltration, adsorption can also happen in hemodial-
ysis process, and they are all explained as follows.
Diffusion
Diffusion is the spontaneous passive transport of solutes from higher concentration to
lower concentration. The process is illustrated in Figure 2.4. Diffusion in hemodialysis
is the transport of water soluble toxins from blood to dialyzate. The transport rate
depends on diffusion coefficients of the solutes in blood, in membrane and in dialyzate;
the concentration gradient across the membrane and the membrane area [22].
Convection
Convection process in hemodialysis is the simultaneous transport of water and solutes
from blood to dialyzate across membranes due to pressure gradient. The rate of convec-
tion depends on the hydraulic permeability, the sieving coefficient of solutes, membrane




Osmosis is the spontaneous net movement of solvent through semi-permeable mem-
branes into a region of higher solute concentration so as to achieve a concentration
balance. The driving force in osmosis is the concentration gradient. The process is il-
lustrated in Figure 2.4. Osmosis in hemodialysis refers to the movement of water across
cell-membranes into blood plasma or interstitial fluid.
Ultrafiltration
Ultrafiltration in hemodialysis is the process of removing excess water from plasma into
dialyzate through difference of pressure. The pressure on the blood side is higher, so
the water moves from a place of higher pressure to one of lower pressure, i.e., into the
dialyzate. This is how fluid gets removed when a patient undergoes hemodialysis. A
typical ultrafiltration process is illustrated in Figure 2.4.
Adsorption
Adsorption is the adhesion of atoms, ions, or molecules from a gas, liquid, or dissolved
solid to a surface. Adsorption in hemodialysis happens when uremic toxins adhere to
the surface of semi-permeable hemodialysis membrane or into the adsorbents inside the
membranes.
2.3 Uremic toxins
Uremic toxins are toxins that accumulate in chronic renal failure patients. These toxins
show various cytotoxic activities in the serum, have different molecular weights and
some of them are bound to other proteins, primarily to albumin. Their concentration
in healthy people and patients with kidney failure are compared in Table 2.2. The
detailed size and chemical structure of the toxins are showed in Table 2.3. These toxins
are normally divided into three groups: water-soluble toxins, protein-bound toxins and
large toxins.
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Table 2.2: Concentrations of free water soluble and protein bond uremic measured in blood of
healthy persons (mean CN )and patients having kidney diseases ((mean CU ), maximum(Cmax))
Reprinted from [23], Copyright(2005), with permission from Elsevier.
Solute CN/µM CU/µM Cmax/µM Group
Urea < 6700 38,333 ± 18,333 76,667 Carbamides
free water soluble solutes
Urea acid < 400 496±265 873 Purines
free water soluble solutes
Creatinine < 106 1204±407 2124 Guanidines
free water soluble solutes




2.4±22 211±365 940 Indoles
protein bond solutes













































251 unknown 220 0.79 0.11 0.54
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2.3.1 Water-soluble toxins
Water-soluble toxins are molecules with molecular weight (MW) less than 500 Da. Urea
and creatinine are representatives[24]. They are highly water soluble and are absent of
protein bounding, therefore easily removed by hemodialysis. They do not necessarily
have toxic activity [25]. Creatinine is the marker of renal function and is chosen as
a representative for water-soluble toxins in this thesis. The increase of creatinine in
serum is usually the result of uremic retention, but it might also be caused by muscle
breakdown. Morbidity and mortality in hemodialysis patients are positively related to
their serum creatinine level [26].
2.3.2 Protein-bound toxins
Protein-bound solutes are a group of uremic toxins that tend to bound to proteins, such
as albumin. They are routinely ignored, as hemodialysis adequacy is typically bench-
marked by urea removal. Increasingly, studies have shown that protein-bound toxins are
related to the progression of chronic kidney disease (CKD), and in the generation and
aggravation of cardiovascular disease [27]. Indoxyl sulfate and p-cresol sulfate are two
representatives. Indoxyl sulfate is derived from tryptophan in dietary proteins (Figure
2.5) while p-cresol sulfate is derived from tyrosine and phenylalanine. They are ex-
creted to urine through the kidney. Their increase in serum indicates the deteriorating
of kidney functions [28].
2.3.3 Large toxins
Large toxins are toxins with molecular weight larger than 500 Da. β-microglobulin is a
prototype. An accumulation of molecules is independently associated with an increased
mortality risk [30]. These molecules can only be cleared by hemodialysis membranes
with pore sizes larger enough for these molecules to cross.
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Figure 2.5: Indoxyl sulfate metabolism. The diagram shows the protein metabolite hypothesis
of indoxyl sulfate (IS) production that is derived from dietary tryptophan. Inhibition of indole
uptake by a gut adsorbent AST-120 reduces IS synthesis. GI tract indicates gastrointestinal
tract; OAT, organic anion transporter. Reprinted from [29].
2.4 Electrospinning
Electrospinning is a technique that can be used to fabricate fibrous composite mem-
branes. A basic electrospinning setup contains three major parts: a high voltage power
supply, a syringe pump and a collector. The setup can be found in Figure 2.6. The
syringe is used to host the polymer solution. When high voltage is applied, the polymer
drop at the tip of the syringe is polarized and then the charged polymer flies to the
collector under strong electrostatic field.
In this thesis, we use electrospinning to fabricate nanofiber composite membranes.
More specifically, these membranes contain polymeric nanofiber as high porous nano-
woven matrix. They also contain nano-filler as adsorbent for the toxins. These mem-
branes are better than currently used hemodialysis membranes and silicon membranes.
Comparing with currently used polymer membranes, composite membranes have clear
pore channels and higher porosity. Comparing with potential silicon membranes, they
have much higher porosity and they are more flexible. Another advantage of these mem-









Figure 2.6: Electrospinning setup.
polymer membranes eliminate toxins only by diffusion. With the addition of adsorption,
we can expect composite membranes to have faster toxin clearance speed.
In this section, we study the theory of electrospinning, which includes charge gen-
eration, taylor cone theory, jet thinning and jet instability. We also discuss the factors
that influence the formation of membranes.
2.4.1 Charge generation
Electrospinning works by generating charge carriers which respond to the applied electric
field. Charge carriers are created by high electric field induced emission (on the order
of 109 to 1010 V/m) and by dissociation processes [31]. Figure 2.7 is the illustration of
charge carries in the needle. We define the syringe needle and solutions within it as a
capillary electrode. With a positively polarized capillary, the negative ions will migrate
to the inner surface of the needle where they will be immobilized. This leaves the inner
volume of the solution with an excess mobile positive charge which can respond to the
electrostatic stress of the opposite electrode. The sharp edges might have field emission
of charges.

































Figure 2.7: Illustration of charge carries in a syringe needle.
a plate electrodes configuration, called “point-plane” geometry. The electric field under
this configuration has highly non-uniform electric field. The increased electric field at









where V is the externally applied voltage, d is the distance from the needle tip to plane
collector, and r is the radius of curvature of the needle point.
Dissociation process happens in liquid solution. The process is affected by ion dif-
fusion and migration in the electric field. Lars Onsager’s equations (2.2)-(2.3) describe




























where, K(E) is the dissociation constant in the presence of an electric field, K(0) is the
dissociation constant at equilibrium without electric field, z1 and z2 are the valences of
the ions, ω1 and ω2 are ion mobilities, q is the electronic charge, E is the electric field, k
is the Boltzmann constant, T is the temperature, and ǫ is the permittivity of the liquid.
After ions dissociate, the negative ions will migrate to the cathode, while the pos-
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Figure 2.8: Schematic diagram of the Taylor cone.
itive ions to the anode, leading to a disrupted dissociation-recombination equilibrium.
The ions will be further immobilized or annihilated by the electrochemical process at
electrodes, which makes recombination impossible [33].
2.4.2 Taylor cone theory
Taylor cone theory was established in 1964 by G.I. Taylor to describe the deformation
of small-volume liquid under high electric field. It asserts that, when a small volume
of electrically conductive liquid is exposed to electric field, it keeps a shape due to
the balance between electric forces and surface tension. If the potential increases to
a critical level, further increase will destroy the balance, and the liquid will acquire
a conical shape with half angle of 49.3◦, called Taylor cone, as shown in Figure 2.8.
A.L. Yrin and D.H. Reneker later modified Taylor cone theory based on experimental
data. They found that Taylor cone theory was only correct for self-similar solution and
that the angle of the cone was 33.5◦ instead of 49.3◦. For non self-similar solution, the
further increased potential after critical potential point will cause the cone to have a
more prolate shape [34].
2.4.3 Jet in flight
Jet in flight describes the process after the jets (solution) are ejected from the Taylor
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Figure 2.9: Schematic illustration of the jets path between the tip of syringe and collector.
path, during which the electrical forces stretch and thin them into a nanofiber, before
arriving at the collector. The process is shown in Figure 2.9.
Jet thinning (Steady region)
As the fluid is ejected from the cone, a continuous thinning liquid jet can be seen.
Hohman and Feng [35, 36] indicated that the surface charge density and the local electric






where K, Q, ρ, χ, E∞,I, and ǫ are the conductivity, flow rate, density, aspect ratio
(χ = D/h0), applied field, electric current, and dielectric constant of air. The current for
electrospinning “circuit” is typically < 1 µA. The measured current follows the equation
(2.5) [38].
i = Qρc = C
χe−HKexpM
γQβV α (2.5)
where, ρc, V,Q,C,M , and H are the initial charge per unit volume, applied voltage,
volumetric solution flow rate, polymer concentration, molecular weight, and needle to
plate distance, respectively. The variables α, β, γ and χ depend on the type of solution.
Beyond the length L, the jet thins much more slowly.
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Figure 2.10: Cone-jets of solution of polyethylene oxide(MW=920 kg/mol). D=45 cm
in all cases. (a) Q=0.02 ml/min, E=0.282 kV/cm; (b) Q=0.10 ml/min, E=0.344 kV/cm;
(c)Q=0.50 ml/min, E=0.533 kV/cm Q=1.00 ml/min, E=0.716 kV/cm. Reprinted from [37],
Copyright(2007), with permission from Elsevier.
Jet instability (Unsteady region)
During the experiment, as the jet grows, it is distorted by one or more fluid instabilities.
The most common mode of instability is whipping (shown in Figure 2.11) [37].
2.4.4 Collector
Collector is the device that collects jets. The shape of the collector can be plate,
rotating drum, wire drum, rotating discs, parallel electrodes and other collecting array,
depending on the purpose of the nanofiber assembly [39].
2.4.5 Parameters influencing electrospinning
In the electrospinning process, the governing parameters that influence volume charge
density and current are the applied voltage (V ), the solution flow rate (Q), the polymer
weight concentration (C), the molecular weight of the polymer (M) and the nozzle-to-
ground distance (H). The volume charge density follows power law which depends on






Figure 2.11: Fiber instability-whipping.
where, Kexp depends on parameters such as intrinsic solution properties, temperature
and humidity, and h is a function of molecular weight (M).
2.5 Spin coating
Spin coating is a commonly used technique to apply thin films to substrates. It was
chosen as another technique to fabricate composite membranes in this thesis. Spin
coating has been used in various applications such as coating of photoresist on silicon
wafers [41, 42, 43], sensors [44, 45], protective coatings [46], paint coatings, optical
coatings [47] and membranes [48]. It can be used to quickly and easily to produce
uniform films over a large area (φ ≥ 30 cm), ranging from a few nanometers to a few
micrometers in thickness [49]. The general spin-coating process is shown in Figure 2.12.
It consists of (1) a dispense step in which the polymer solution is deposited onto the
substrate, and then (2) a speed spin step to thin the solution, and (3) a drying step to
eliminate excess solvents from in step (4) the resulting film.
Spin speed, acceleration, spin time, fume exhaust, viscosity of the solution are factors
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Figure 2.12: Demonstration of a typical spin coating process.
related to film thickness and uniformity.
2.6 Zeolites
Zeolites are microporous, aluminosilicate minerals commonly used as commercial ad-
sorbents and catalysts. Zeolites have been chosen as adsorbent in this thesis. Here we
discuss their structure and chemical composition.
2.6.1 Chemical composition of zeolites
The general formula for most zeolite are given as [40, 50]:
|Mx(H2O)γ |[AlxO2tSit−x]− IZA,
where, the guest species are represented in bars(| |). The host framework is represented
inside brackets ([ ]). M represents a cation, x is the number of framework Al atoms
in the unit cell, γ is the number of adsorbed water molecules, t is the total number
of framework tetrahedral atoms in the unit cell (Al+Si) and IZA (International Zeolite
Association) is the code for the framework type assigned by the Structure Commission
of the International Zeolite Association.
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Figure 2.13: Several representation of the basic building unit of zeolites, the tetrahedron.
2.6.2 Structure of zeolites
Zeolite’s structure is based on a connected framework of SiO4 and AlO4 tetrahedra by
sharing of oxygen atoms. Here we introduce the basic building and composite building
units of zeolites.
Basic building unit (BBU): the tetrahedron
All zeolite frameworks can be built by periodically linking the a basic building unit
(BBU), the tetrahedron (Figure 2.13). In the center of the tetrahedra are atoms Si4+,
Al3+ or P5+, while in the corners are oxygen anions (O2−). The combination could be
SiO4, AlO4 ,PO4, etc.
Composite building unit (CBU)
Composite building units (CBUs) of zeolites can be formed by linking together groups
of basic building units (BBUs). The simplest example of CBUs are rings. In general, a
ring containing n tetrahedra is called n-ring. The most common rings contain 4, 5, 6,
8, 10 or 12 tetrahedral [51, 52]. Figure 2.14 shows the pore size and structure of 8-ring.
The size of other rings is shown in Table 2.4. Further combining n rings can lead to
larger CBUs with diverse and interesting structures, as shown in Figure 2.15. Cages can
contain cation, water molecules, small organic molecules, and so on. One-dimensional
CBUs which are composed by rings (either identical or different) are called chains.
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Figure 2.14: Illustration of 8-ring.














Figure 2.15: Some examples of polyhedral composite building units (cages) with their cor-
responding pore symbols and common names. The nodes are tetrahedrally coordinated atoms
such as Si or Al. Bridging oxygen atoms have been left out for clarity. Reprinted from [50],
Copyright(2003), with permission from Elsevier.
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Pores, cages, cavities and channels
The n-rings defining the face of a polyhedral CBU are called windows or pores. Poly-
hedra whose faces are no larger than 6-rings are called cages, since they are too narrow
for molecules larger than H2O to pass. Polyhedra with at least one face larger than
6-rings are called cavities. The extended pores in one, two, or three dimensions which
allow diffusion of guest species (larger than 6-rings) are called channels. An important
characteristic of zeolites is the effective width of channels, which is limited by the small-
est free aperture along the channel. By knowing the structure of zeolites, it is possible
to calculate the effective width of the channels.
2.6.3 Molecular sieving
Molecular sieves are porous materials that selectively adsorb molecules of specific sizes.
Zeolites are the most commonly used crystalline materials for molecular sieves. They
have pore sizes from 0.3 to 1.0 nm and pore volumes from 0.10 to 0.35 cm3/g. Typical
zeolites’ pore sizes include: (1) small pore zeolites that have eight-ring pores with free
diameters of 0.30-0.45 nm (eg, zeolite A), (2) medium pore zeolites that have ten-ring
pores with free diameter of 0.45-0.60 nm (eg, stilbite and silicalite (MFI)), (3) large
pore zeolites that have 12-ring pores with free diameters of 0.6-0.8 nm (eg, Mordenite
and Faujasite) and (4) extra-large pore zeolites that have 14-ring pores (eg. UTD-1).
Additionally, the zeolite frameworks are somewhat flexible; their size and shape change





The composite membranes we propose mainly depend on adsorbents to eliminate toxins.
In this chapter, we present a literature review on adsorbents used in renal therapy. This
provides us a good guidance in choosing suitable adsorbents. We also survey other
renal replacement therapies that use adsorbent technologies, such as hemoperfusion
and wearable kidneys.
3.1 Hemoperfusion
Hemoperfusion (HP) is a procedure to treat drug overdose and poisoning [54], which was
introduced in the 1940s [55]. It was adopted in clinic in the 1970s and 1980s [56, 57, 58]
and used infrequently for treating acute intoxication [59]. A typical hemoperfusion sys-
tem is shown in Figure 3.1. It consists of a blood circuit including blood pumps and
pressure monitors that are identical to hemodialysis, but with a cartridge containing ad-
sorbents (charcoal, activated carbon or resin). Anticoagulated blood is pumped through
the cartridge, where drugs or poisons are removed by adsorption. Table 3.1 lists several
adsorption cartridges available [60]. HP can lead to a number of medical complications,
including thrombocytopenia, leukopenia, hypocalcemia, and hypoglycemia. Its use has
been declining due to the development of high-flux hemodialysis, which has a lower cost
and lead to fewer medical complications. However, HP is still a valid alternative for
Table 3.1: Some available hemoperfusion devices.
Manufacturer Device Sorbent Type
Clark Biocompatible system Carbon
Gambro Adsorba Norit carbon
Nextron Medical Hemosorba Ch-350 Petroleum bead carbon
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Figure 3.1: Schematics of a typical hemoperfusion system. Reprinted from [53], Copy-
right(2016), with permission from John Wiley and Sons.
poisons with a low concentration distribution and high degree of protein binding [61].
3.2 Wearable kidney (WAK)
Current hemodialysis uses large amounts of hemodialysis fluid in a one time pass [53].
The size of existing hemodialysis system can be scaled down significantly if the amount
of required dialyzate is significantly reduced. This can be achieved with the utilization
of an adsorbent system to regenerate dialyzate [64, 65, 66].
Wearable kidneys are miniatured hemodialysis devices that patients can “wear”
and perform hemodialysis as they move around. These devices work by regenerating
and reusing a small volume of hemodialysis fluid in a closed-loop cycle. Miniaturized
hemodialysis models that are wearable can eliminate one of the long-standing hemodial-
ysis problems, specifically patient mobility and non-continuous hemodialysis. Although
the models of WAK may differ from each other, the dialyzer is the heart of the system.
A schematic of a WAK is shown in Figure 3.2 (a) while a prototype is shown in Figure
3.2 (c). Some famous patented designs of WAKs that predominantly utilize adsorbents
to generate dialyzate include Yoshida [67], Henne[68], Davankov [69], Granger [70], and
Gura [62, 71]. The Gura WAK is currently undergoing clinical trials[72] and is one of
the most viable design.
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Figure 3.2: A wearable kidney schematic (a), adsorbent(b) and the Gura wearable kidney(c).
(a) Reprinted from [62], Copyright(2008), with permission from John Wiley and Sons, (b)
Reprinted from [53], Copyright(2016), with permission from John Wiley and Sons, (c) Reprinted
from [63], Copyright(2007), with permission from Elsevier.
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Table 3.2: Comparison of hemoperfusion,hemodialysis and wearable kidney.
Categories Hemoperfusion Hemodialysis Wearable
Kidney
Mechanism Adsorption Diffusion convection Diffusion
Usage Poisoning/Drug overdose Kidney failure Kidney
failure




All the wearable kidneys design need regeneration cartridges. The serial REDY
models of regeneration cartridge [73], based on sorbent and enzyme technology, were the
first truly portable hemodialysis systems and were widely used throughout Australian
hospitals. This cartridge was used for purification of the recirculated hemodialysis
fluid. It consists of urease layer to convert urea, activated carbon layer for adsorption of
non-urea organic toxins, zirconium phosphate to bind potassium and (urease-generated)
ammonium, and zirconium oxide & zirconium carbonate layer to remove phosphate [57].
This combination of sorbents and urease formed the basis for the WAK developed by
Davenport et al [63].
In this chapter, we discussed hemoperfusion and wearable kidneys. In the previous
chapter, we also discussed the hemodialysis process. Table 3.2 compares these three
therapies in terms of mechanism, usage and the key components.
3.3 Adsorbents
Adsorbents are materials that can adsorb molecules into/onto their surface. They are
the key components in hemoperfusion and wearable kidneys. Resin, charcoal and acti-
vated carbon are the adsorbents that have been used to eliminate uremic toxins.
Charcoal was the first adsorbent used to remove uremic toxin, as reported by Yatzidis
[74]. From 1964 until now, activated carbon has been used in hemoperfusion, which is
especially useful to treat acute poisoning, intoxication and hepatic failure [75, 76, 77].
Activated carbon is a logical choice as an adsorbent because it has a large surface area
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[78, 79], good affinity for both organic and inorganic contaminants [80] and amphoteric
properties [81]. However, activated carbon’s major drawback lies in the indiscriminate
adsorption of both uremic toxin molecules as well as life sustaining molecules from blood
[82].
Zeolites are other promising candidates to adsorb uremic toxins. Wernert and col-
leagues reported that MFI zeolites are able to adsorb uremic toxins that have small
molecular size [23, 83]. The adsorbent level for urea is slightly lower or equal to that of
activated carbon. Physical and chemical modification of zeolites through ion exchange or
surfactant can improve their affinity towards some specific uremic toxins, thus improv-
ing the overall adsorption capacities of zeolites [23]. Unlike activated carbon, zeolites
possess better selectivity and affinity toward specific uremic toxins. The ability for
selective adsorption alone is helpful in solving problems existing in hemodialysis [53].
Although the incorporation of adsorbents into the membranes could minimize the
shortcoming of hemodialysis. However, a direct contact between adsorbents such as ac-
tivated carbon and blood leads to various problems and complications, such as hemolysis
and blood coagulation [83]. Even though heparin can be used as a conventional way to
prevent blood from clotting [75], heparin overdose could lead to further complication
such as bleeding and bruising [84].
A growing and feasible trend to reduce complications caused by the contact of ad-
sorbents with blood is to improve the biocompatibility of adsorbents [85]. Attempted
methods to improve the hemocompatibility of activated carbon and carbon nanotube
adsorbents include coating and encapsulation of the adsorbents. A wide range of hemo-
compatible membranes such as cellulose nitrate [86] and plyhydroxyethyl methacrylate
[87] have been used to coat adsorbent particles. Heparin [88, 89] has been used to coat
adsorbent particles in order to prevent platelet adhesion and blood coagulation. How-
ever, the uremic toxin adsorbing efficiency of coated or encapsulated adsorbent systems
is lower than that of bare adsorbents due to partial blocking of adsorption sites [90].
Other than coating and encapsulation, functionalization method proved to be benefi-
cial in improving hemocompatibility of adsorbent particles. This method involves the
introduction of hydrophilic functional groups into the surface of adsorbent particles [91].
Our proposed composite membranes incorporate zeolites inside the membranes. It
has good biocompatibility and it has been used as drug delivery material [92] and as
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coating material for biomedical implants [93].
3.4 Dialyzer membranes
Dialyzer membranes are the semi-permeable membranes in a dialyzer that allow toxins
to pass while retaining biological molecule during hemodialysis. Synthetic membranes
are by far most frequently used hemodialysis membranes, with an increasing market
share. They are regarded as the most biocompatible hemodialysis membranes, and, for
that reason, have replaced cellulose membranes since mid-1990s. It is expected that
they will also replace modified cellulose membranes in the near future.
The majority of synthetic hemodialysis membranes currently used is hydrophobic.
The addition of additives or copolymers in the production process can make them more
hydrophilic. These membranes are in the shape of hollow fibers. These hollow fiber
membranes are extruded through a spinneret followed by phase inversion and immersion.
Their skin is formed by partial evaporation of the solvent and their structure is defined
by phase separation. The major purpose of these membranes is to achieve a high
porosity, in order to mimic the kidney filtration process [94], and to remove middle
molecules and higher molecular uremic toxins. It was calculated that the pore size of
the membranes should be larger 5 nm in order to remove large molecular uremic toxins
and smaller than 8 nm in order to prevent the leaking of albumin [95].
Commonly available hemodialysis membranes can be classified into three groups: re-
generated cellulose, substituted cellulose and synthesized polymers. These synthesized
polymers include AN 69, PS, PA, PAN, PMMA, PES and polycarbonate(PC). PAN
and PS have relatively more publications compared with other polymers. Bazargan
[96] shows that by electrospunning 12 wt% PAN in DMF we can get PAN fiber mem-
branes with diameter of 165 ± 16 nm and porosity of 91.7%. Bastani [97] fabricated
PAN nanofiber membranes with pore size around 5-65 nm which could filter 7-40 nm
particles from waste water. Since PAN nanofiber membranes have pore size similar to
hemodialysis membranes, as well as high permeability, it was chosen as candidate for our
electrospinning experiment. On the other hand, PES[21, 98] is a good polymer to make
membranes through spin-coating. PAN and PES are two polymers used in this thesis,
thus the following section reviewed their histories and current status as hemdodialysis
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Figure 3.3: The molecular structure of polyacrylonitrile.
membranes.
3.4.1 Polyacrylonitrile
The first dialyzer with polyacrylonitrile (PAN) (structure shown in Figure 3.3) mem-
brane was produced by Gambro and marketed under brand name AN69 R©. This mem-
brane is highly permeable and symmetric. It is a blend of hydrophobic polyacrylonitrile
with hydrophilic methallylNa-sulfonate. It has good distributed medium-sized pores in
high density over the homogeneous polymer. It is used till date and has been a great
success over the years.
Another PAN producer is ASAHI (PAN, PAN DX, ASAHI Medical, Japan). Their
membrane consists of hydrophobic monomers, acrylonitrile, methacrylate, and hydrophilic
acrylic acid. The membrane is asymmetric and has a skin layer with pores in a wide
range.
Since 1990, it has been reported that the electronegativity of AN69 R© is responsi-
ble for the anaphylactoid reactions in patients who are taking angiotensin-converting
enzyme (ACE) inhibitors, since contact phase system was activated due to the genera-
tion of bradykinin [99, 100]. Therefore, AN69 R© is contraindicated in patients on ACE
inhibitor therapy. To eliminate contact activation, AN69 R©ST was developed through
surface-modification. Polyethyleneimine was used to coat the surface of the membranes
in order to neutralize the negative charges [101]. Additionally, heparin binds to the
surface of AN69 R©ST during priming process and no further heparin is needed during
treatment, which may be beneficial in patients at bleeding risk [102].
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Figure 3.4: The molecular structure of polyethersulfone.
3.4.2 Polyethersulfone
More than 18 models of dialyzers made from polysulfone and polyethersulfone (struc-
ture shown in Figure 3.4) are currently used in clinic, which attest the great success of
these membrane polymers for hemodialysis. They fit all the requirements of hemodial-
ysis membranes such as good physical strength and chemical resistance, biocompati-
blility, and easy sterilization. The first polysulfone membrane, Fresenius Polysulfon R©
was introduced by Fresenius in 1983. It has an asymmetric and microreticular struc-
ture. DIAPES R© and Polyamix are other commonly used polyethersulfone membranes.
Both polysulfone and polyethersulfone are hydrophobic polymers. Blending with a hy-
drophilic copolymer (polyvinylpyrrolidone) is a common method to make the membranes
more hydrophilic, which can lead to a better diffusive performance.
3.5 Design Methodology
In this section, we first summarized the membrane design criteria, and then presented
experiment testing methods used in this thesis.
3.5.1 Membrane design criteria
In order to make better hemodialysis membranes, the following criteria need to be
followed:
• Membrane fabrication methods should be easy to realize in the lab.
• Adsorbents used in the membranes should be stable and non toxin in biological
environment, they should also be selectively adsorb uremic toxins and not to
adsorb biological molecules.
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• Pore size of membranes should be large enough for toxins to pass and small enough
to prevent albumin to pass.
• Membranes should be biocompatible.
• Membranes should have suitable permeability.
• Membranes should be able to remove both water soluble toxins and protein bound
toxins.
3.5.2 Experiment methods
In this thesis, we used two simple membranes fabrication methods (electrospinning and
spin coating) to fabricated hemodialysis membranes in the lab. We also tested whether
these membranes could fulfill the membrane design criteria we mentioned above through
the following experiment methods.
Scanning electron microscope and Si mapping
Scanning electron microscope (SEM) is a common technique to produces images of
a sample by scanning it with a focused beam of electrons. In this thesis, we used
scanning electron microscope (SEM) method to test the morphologies of membranes.
These images can not only infer the fiber diameters of electrospinning membranes,
but also show the channel of spin coated membranes. Si mapping membranes show the
distribution of Si elements in the membranes and we can infer the distribution of zeolites
in the membranes.
Thermalgravimetric analysis
Thermalgravimetric is a common method to measure the sample weight changes as a
function of increasing temperature. It is normally used to determine mass loss or gain
due to materials’ decomposition, oxidation or evaporation of chemical with low boiling
points. In this thesis, we use this method to determine the weight percentage of zeolites
in polymer membranes.
The uncertainly of this method might caused by the initial samples, the sample need




Dynamic laser scattering can be used to determine the size distribution of particles.
It normally consists of a laser, a sample, a photo detector and a correlator. When the
laser lights hits the small particles in the sample, the light scatters in all directions. The
photo detector detects the intensity fluctuates over time and the correlator correlates
the particle size with scattering intensity.
The uncertainly of this test can be caused by the size of particle core and surface
structures, particle concentration, and types of ions in the medium. In order to mini-
mize the uncertainly of this test, all the particle size are tested and compared at same
concentration and in the same medium.
Zeta potential
Zeta potential of particle is measured by applying an electric field across the sample
dispersion. Particles with a zeta potential will migrate toward the electrode with a
velocity proportional to zeta potential. By measuring the migrating velocity of these
particles, zeta potential of particles can be deduced.
The uncertainly of zeta potential can caused by pH of medium and ions strength in
the medium.
Ultraviolet spectroscopy
Ultroviolet spectroscopy is a common method to measure the concentration of molecules.
It happens because molecules containing π-electrons can adsorb ultraviolet to excite
these electrons to higher molecular orbitals.
Measurement uncertainly can caused by spectral bandwidth, wavelength of excita-
tion light, purity of light and high concentration of samples.
Fluorescence spectroscopy
Fluorescence spectroscopy intensity can be used to represent sample concentrations.
In fluorescence, the molecular is first excited by adsorbing a photo from its ground
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electronic state to various vibrational states. Collisions with other molecules caused the
excited molecule to lose vibrational energy and reaches the lowest vibrational state. In
the process, a photo is emitting.
Measurement uncertainly can caused by the instruments, such as light source inten-
sity, wavelength characteristics, intensity of wavelength at all wavelengths, and cuvettes.
It can also caused by sample distortions, re-adsorption and high concentrations of sam-
ples.
Water flux
Water flux of membranes is the rate at which water permeates a membrane.
Water flux uncertainly is related to membrane thickness, membrane pore size and
pore channels and membrane surface properties.
3.5.3 Data calculation methodology
Fiber diameter
The fiber diameter data of polyacrylonitrile-zeolite are presented either as histogram
figure or average bar figures. We collected around 50 sample diameter by using 5 images
from scanning electron microscope and measured the fiber diameter with the help of
Image J.
Ultraviolet adsorption
All the data related to creatinine adsorption are measured through ultraviolet adsorp-
tion. We first get a standard creatinine adsorption function trough linear regression
between the ultraviolet intensity with creatinine concentration. Then, we tested our
samples for three times and calculated the sample concentration through the linear
function. The data is presented in bar figure with the height of the bar represents the
average, the error bar represents the min and max data of these three repeated samples.
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Fluorescence adsorption
Fluorescence spectrum are used to represent the concentration of indoxyl sulfate in
samples. As we know, the environment change such as pH and types of ions will affect
the fluorescence intensity of indoxyl sulfate. For each environment, both background
data (as control) and sample data are presented.
Others
Scanning electron microscope and thermalgravimetric analysis data are used without
further change. The water flux table in this thesis is created with the average data of






In this chapter, we show that the proposed composite membranes are able to adsorb
water-soluble toxins. Four types of zeolite powders are tested and their abilities to
adsorb creatinine are compared. An electrospinning device is set up in order to fabricate
fibrous membranes with these adsorbents. Finally, the membranes are tested and their
abilities to eliminate creatinine are compared.
4.1 Introduction
Although several types of hollow fiber hemodialysis membranes which can eliminate ure-
mic toxins though diffusion process are used in clinics [16, 103, 104, 105], the hemodial-
ysis process is still inconvenient, time consuming and expensive.
Patients with kidney failure have uremic toxins buildup, which are toxic to the
body at high concentration and lead to a complex mixture of organ dysfunctions if
left untreated [106]. Urea and creatinine are the common uremic toxins accumulated
in chronic renal failure patients. The average concentration of urea and creatinine in
patients are 38,333 ± 18,333 and 1204 ± 407 µmol, while that of normal health persons
are less than 6700 and 106 µmol respectively [23].
Uremic toxins can also be eliminated by adsorption mechanisms other than the tra-
ditional diffusion mechanisms used in dialyzers nowadays. In previous research[107, 108,
109, 110], zeolite powders were used to adsorb uremic toxins. Zeolites are the most com-
monly used crystalline materials for molecular sieves since various types can be easily
obtained either from nature or synthesized in labs. The molecular sieve properties of
39
zeolites as well as the fact that zeolites are non-toxic and very stable under physiolog-
ical conditions make them a good alternative method to eliminate uremic toxins. By
analyzing the structure of a given zeolite, especially its pore size information, one can
estimate what molecules the zeolite can adsorb.
In order to use zeolites to adsorb uremic toxins, zeolites can be incorporated into
a nonporous polymer to form a composite membrane which has both the properties of
molecular sieving and processability [111]. Polymer membranes with zeolite fillers were
investigated in depth for water purification [112, 113] and gas separation [114, 115].
Nonwoven nanobrous membranes, which can be produced through a simple electrospin-
ning method, are an excellent choice for incorporating zeolite powders. The fibrous
membranes produced by electrospinning have high porosity, fine fiber diameters, large
surface area-to-volume ratio, good interconnected pore structures and great permeabil-
ity [116, 117].
To fabricate a hemodialysis membrane, zeolites were incorporated into electrospun
PAN (polyacrylonitrile) polymeric nanofiber membranes. PAN porous membranes have
a variety of excellent characteristics including good thermal and mechanical stability,
tolerance to bacteria and photo irradiation [118], and excellent membrane forming prop-
erties [117]. PAN membranes made through traditional phase inversion method are used
as dialyzer membranes in clinic [119, 120, 121].
In this chapter we fabricated and characterised PAN nanofiber membranes and PAN-
zeolite composite membranes with two types of zeolite, 840-NHA and 940-HOA, at
differing concentrations (5, 10, 15, 20, 25, 30 & 35 wt%). Then, the creatinine absorption
capacity of both free zeolites and incorporated zeolites were evaluated. We anticipate
that PAN-zeolite membrane will have a quick speed to eliminate uremic toxins because
of the fast adsorption speed of zeolites. The fibrous PAN-zeolite membrane, which
combines adsorption and diffusion together, could be a new choice for hemodialysis
membranes.
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4.2 Materials and methods
4.2.1 Materials
Polyacrylonitrile (PAN) with molecular weight of 150,000, dimethylformamide (DMF)
and creatinine were purchased from Sigma Aldrich, Co. HSZ-series zeolites 500-KOA
(L), 720-KOA (Farrierite), 840-NHA (ZSM-5) and 940-HOA (Beta) powders were pur-
chased from Tosoh. Ultrapure water was also used.
4.2.2 Sample preparation
Preparation of nanofibrous PAN membranes
PAN electrospun solutions were prepared by dissolving 6 wt%, 8 wt% and 10 wt% PAN
powders in DMF at 60 ◦C for 12 h. The PAN nanofibrous membranes were prepared
using a laboratory set-up electrospinning equipment. The electrospun voltage was 22.5
kV, feed rate was 1 ml h−1 and tip to collector distance was 15 cm. The relative
humidity and temperature were kept between 48-52% and 23 − 26 ◦C respectively. In
all experiments, 21 gauge needles were used.
Preparation of PAN-zeolite composite membranes
PAN-zeolites solutions were prepared by adding zeolite powders into 10 wt% PAN elec-
trospun solution from section 2.3.2. The composite solution was further stirred at room
temperature for 12 h and ultrasonicated for 1 h during the stirring process. Composite
solutions with zeolite to PAN polymer ratio varied from 10:100, 15:100, 20:100, 25:100,
30:100 to 35:100 were prepared. If a sample contains 10 wt% 840-NHA in PAN poly-
mer, the samples were named 10-840, other samples were also named accordingly. The
electrospinning factors were kept the same as section 2.3.2 except for the tip to collector




Scanning electron microscopy (SEM)
The morphology of PAN and PAN-zeolite membranes was examined using a Zeiss scan-
ning electron microscope. The diameter of the fibers was measured by ImageJ software
for 50 times. The PAN membranes and PAN-zeolite membranes were also examined by
energy dispersive X-ray spectroscopy (EDX) equipped in SEM.
Thermal gravimetric analysis (TGA)
Thermal gravimetric analysis (TGA) of the samples was conducted using the Q500
TGA instrument from TA Instruments. The temperature scans were taken from room
temperature to 800 ◦C at 10 ◦C min−1 in an ambient atmosphere at an air ow of 20 ml
min−1.
Adsorption studies of zeolite powders
UV-Visible spectrophotometer (Ultraspec 2100 pro) was used to measure the absorbance
of the creatinine solution. Creatinine solutions with various concentrations (50, 100, 150,
200, 250, 312.5 and 400 µ mol L−1were made by adding creatinine powders into beakers
with ultrapure water and then stirred overnight. An UV calibration standard line for
creatinine in ultrapure water was prepared based on the absorption value of creatinine
solutions at 234 nm. Creatinine solutions with concentration of 0, 50 , 100 , 150 , 200
and 312.5 and 400 µmol L−1 were tested for drawing the UV calibration standard line.
Creatinine adsorption capacity of free zeolite was first tested by the following procedure.
0.025 g 500 KOA, 720 KOA, 840-NHA and 940-HOA powders were added into 4 vials
with 10 ml 200 µmol L−1creatinine solution and were shaken at 37 C for 3 h at a speed
of 165 rpm in a shaker (C25, New Brunswick Scientific, USA). The adsorption speed
of 940-HOA powders was further measured using the same procedure by shaking them
for 0, 5, 10, 20 minutes and 3 h. Finally, the adsorption capacity of 940-HOA powders
in 50 , 200 , 312.5, and 625 µmol L−1 creatinine solutions were also measured for 20
minutes.
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Adsorption study of zeolites incorporated in membranes
Creatinine adsorption capacities of different composite membranes were tested in a flow
state according to the following procedure. First, composite membranes with a diameter
of 10 mm were cut and positioned in a syringe filter cartridge (EMD Millipore, CA).
Then, 200 µmol L−1 creatinine solution was introduced into the inlet of the cartridge
to flow through the membrane and exit through the outlet at the flow rate of 1 ml h−1
for 3 h. Finally, UV absorption spectrums of solutions collected from the outlet were
measured. Three samples of each type of membrane were tested. The creatinine ad-
sorption capacity of 30-940 membranes with different thicknesses were further measured
following the same procedure.
4.3 Results and discussion
4.3.1 Data presentation methods
In this chapter, all the data related to adsorption test are presented through bar figures.
In these figures, the height of the bar is the average value and the error bar is the range
of value. The data are presented in this way to show the value range of these data.
The average diameter of fibers are also presented using bar figure. The height
represents the average fiber diameter of 50 samples measured using Image J based on 5
SEM images.
4.3.2 Fabrication of PAN membranes
Electrospinning is a process based on electrohydrodynamics to form continuous thin
fibers, which can further form fibrous membranes [122]. This membrane fabrication
method is simple, easy and cost-effective. Various polymers have been used in elec-
trospinning processes [123, 124, 125, 126]. Among them, electrospun PAN membranes
have attracted much attention due to its excellent thermal stability and insolubility to
most solvents [127]. PAN based membranes have been widely used in water treatment
[128, 129], protein filtration and dialysis. In this chapter, PAN fibrous membranes with
different concentrations were fabricated by adjusting voltage, tip to collector distance,
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flow rate, temperature and humidity during the electrospinning process. The best con-
ditions to get smooth fibers were at 22.5 kV with a flow rate of 1 ml h−1 in a relative
humidity of 50% at 25 ◦C. These conditions were used in the following experiments.
The morphology of the fibers with 6 wt%, 8 wt% and 10 wt% of PAN in DMF is shown
in Figure 4.1. Smooth fibers with rare beads are observed in all the figures. The rare
beads in Figure 4.1 have probably formed due to the disturbance of electrospinning
parameters, such as flow rate, humidity, voltage and current. The diameter of fibers
with 6 wt% of PAN is 141 nm, which is the thinnest among all the three samples. The
diameter of 8 wt% of PAN is 411 nm and that of 10 wt% of PAN is 673 nm. These
average fiber diameters are measured by collecting 50 samples by Image J using 4-5
different SEM images. Typically, the fiber diameter would increase with increased poly-
mer concentration when other fabrication factors are unchanged. Solutions with more
than 15 wt% of PAN in DMF were not used since their viscosities were too high for the
electrospinning apparatus.
4.3.3 Fabrication of PAN-zeolite membranes
Polymeric membranes filled with zeolites have their advantages since they combine
molecular sieve property of zeolites and processability of polymers12. Polymer-zeolite
membranes have been used for gas separation [130, 111], ethanol-water separation [131]
and water treatment [132]. To maintain a relatively high flow rate of 1 ml h−1, the 10
wt% PAN in DMF was chosen as the polymer solution base for incorporating zeolites.
To better distribute the zeolites within the polymer, the composite solution was stirred
for over 12 h before electrospinning. Furthermore, the solutions were ultrasonicated
twice for 30 min during the stirring process.
Figure 4.2 shows SEM images of PAN-zeolite composite membranes with 940 (10
& 30 wt%) and 840 (25 & 30 wt%). In these images, a mix of bead and fiber mor-
phology can be observed. The formation of beads was due to relatively large zeolite
particle sizes (0.67-2 µm) when compared with fiber diameters (277-419 nm, shown
in Figure 4.4). The average fiber diameters used in Figure.4.4 were collected using 5
SEM images by Image J, the data presented in the figure is the average of 50 measured
data. Another potential reason was due to poor distribution or aggregation of zeolite
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Figure 4.1: SEM images and diameters of electrospun PAN nanofibers produced in DMF with
polymer concentrations of 6 wt% (a), 8 wt% (b) and 10 wt% (c).
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Figure 4.2: SEM images of PAN-zeolite nanofibrous composite membranes. 10-940 (a), 30-940
(b), 25-840 (c) and 30-840 (d). (PAN is 10 wt% based)
Figure 4.3: Creatinine adsorption speed of 940 zeolites in 200 µmol L−1 creatinine solution.
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Figure 4.4: Fiber diameters comparison between membrane with various zeolite at different
concentration.
particles. However, smooth nanofibers existed between the beads. Figure 4.4 shows a
comparison between the average fiber diameter of PAN and PAN-zeolite membranes.
The fiber diameter of 10 wt% PAN membrane without zeolites was 675 nm while the
fiber diameter in the membrane with 10 wt% 940 (Figure 4.2 (a)) was 277 nm and that
in the membrane with 30 wt% 940 (Figure 4.2 (b)) was 398 nm. It further indicated
that the fiber diameter in the membrane with 25 wt% 840 (Figure 4.2 (c)) was 419
nm while that in the membrane with 30 wt% 840 (Figure 4.2 (d) was 277 nm. From
these data we know that the membrane with zeolites had decreased fiber diameter when
compared with PAN membrane and the fiber diameters in PAN-zeolite membrane were
relevant to zeolite type (size and shape) and concentrations. The properties of zeolites
used in this paper are provided in Table 4.1.
To further determine the successful incorporation of zeolites into the membrane,
SEM/Si-mapping images are presented in Figure 4.5. Silicon atom was chosen for it
existed in zeolites, but not in PAN polymers. Si-mapping analysis further presented
the Silicon atomic percentages in PAN and PAN-zeolite membranes, show in Table 4.2.
There are merely 0.07% Silicon atoms in PAN membranes while 14.01% in the mem-
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Table 4.1: Characteristic data of various zeolites used in this study, supplied by Tosoh Corpo-
ration.
500KOA 720KOA 840NHA 940HOA
Cation Type K K NH4 H
SiO2/Al2O3(mol/mol) 6.1 18 40 40
Na2O(wt%) 0.25 1.3 0.05 0.05
K2O(wt%) 16.8 5.6 - -
Surface Area(BET, m2/g) 290 170 330 530
Cystal Size(µm) 0.4 ≤ 1 2x4 0.5-1.0
brane with 10 wt% 940. Figure 4.5(a, b) is the Si-mapping of 10 wt% 940-HOA PAN
membranes; no aggregation of Si was observed. Contrarily, large areas of Si aggrega-
tion were observed in membranes with 30 wt% 940-HOA (Figure 4.5 (c, d)). Uniform
distributions of zeolite within the membrane were harder to achieve when incorporating
higher concentration zeolite. Similarly, mildly aggregation were observed in Figure 4.5(e,
f), which had 25 wt% of 840-NHA.
TGA testing was further carried out to precisely determine the percentage of zeolites
inside the membranes. At 800 ◦C, PAN polymer is totally burned and only zeolites are
left on the pan. As indicated in Figure 4.6, PAN membrane (Figure 4.6(a)) had 0 weight
left at 800 ◦C. 10-10940 (Figure 4.6(b)) had 10% weight left at 800 ◦C. This indicated
that 100% of the fed zeolites are incorporated inside the membranes. Similarly, 10-
20940 (Figure 4.6(c)) had 18% weight left at 800 ◦C, which indicated that 90% of the
fed zeolites (20 wt% 940) were incorporated into the membranes. The membranes fed
with 30 wt% zeolite had around 24 wt% of zeolites inside the membrane (as shown
in 10-30 940, Figure 4.6(d)). From the TGA analysis we can see that the deviation
between the zeolite in feed and zeolites in membrane grew larger with increased zeolite
feeding percentages. The date from Table 4.2 further supported this.
The above analysis shows that zeolite-PAN nanofiber membranes can be successfully
fabricated through the electrospinning method. However, with increased zeolite fed
percentage, it is harder to incorporate all the zeolites in the membrane and higher
percentage of zeolites tend to coagulate inside the membranes.
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Figure 4.5: SEM/Si mapping images of zeolite-PAN membrane with zeolites: 10-940 (a) with
Si-mapping (b), 30- 940 (c) with Si-mapping (d) and 25-840 (e) with Si-mapping (f).
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Figure 4.6: TGA analysis of composite membranes.
Table 4.2: Summaries of TGA test results: Comparison of zeolite percentages in feed and in
membrane.
Sample Zeolites in feed(%) Zeolite in membrane(%) Deviation(%)
10 0 0 0
10-10940 10 10 0
10-15940 15 15 0
10-20940 20 17.5 12.5
10-25940 25 21 16
10-30940 30 24 20
10-35940 35 24 31
10-10840 10 10 0
10-20840 20 15 25
10-25840 25 22 12
10-30840 30 22 26.67
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Figure 4.7: Creatinine adsorption level of zeolites in 200 µmol L−1 creatinine solution for 3 h.
4.3.4 Creatinine adsorption capacity of zeolites
To determine the creatinine adsorption capacity of zeolite, several experiments were
designed and carried out. Figure 4.7(a) presents the adsorption capacity of various
zeolite in both 200 µmol L−1 creatinine solutions for a 3 h period. 500-KOA were
non-adsorbent to creatinine since their pore size was smaller than that of creatinine
[133]. 720-KOA and 840-NHA reduced 10% and 42% of creatinine in 200 µmol L−1
creatinine solution. 940-HOA had the best creatinine adsorption capacity; almost all the
creatinine from both 200 µmol L−1 and 50 µmol L−1 creatinine solution was adsorbed.
Figure 4.7(b) exhibits the creatinine adsorption capacity of zeolites by zeolite mass.
940-HOA
′
s creatinine adsorption capacity is as high as 9050 µg g−1 in a 200 µmol L−1
solution. This experiment revealed that creatinine adsorption capacity was related to
zeolite type.
940-HOA was chosen to further evaluate its creatinine adsorption speed. Figure 4.3
demonstrates that the adsorption speed of zeolites was very quick, 0.025 g of 940-HOA
powders adsorbed all of creatinine from 10 ml 200 µmol L−1 creatinine solution in 5
min.
To further reveal how initial creatinine solution and adsorption time affected crea-
tinine adsorption capacity of zeolites, 940-HOA powders were added to creatinine solu-
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Figure 4.8: Creatinine adsorption percentages of 940-HOA zeolites in different creatinine con-
centrations for 20 min.
Figure 4.9: Creatinine adsorption capacity of 940-HOA zeolites in different creatinine concen-
trations for 20 min.
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tions with concentrations from 50 to 625 µmol L−1 for 20 min. Figure 4.8 showed that,
in 20 min, 940 could adsorb 100, 100, 90, 76 and 70% of creatinine from 10 ml 50, 200,
312.5, 400 and 625 µmol L−1 creatinine solution correspondingly. To express the data
in adsorption capacity method, 940-HOA zeolite exhibited higher adsorption capacity
with increased creatinine concentration, as shown in Figure 4.9. It had the lowest ca-
pacity (4930 µg g−1) in 50 µmol L−1 creatinine solution, a gradually increased capacity
in (11236, 13621 &16126 µg g−1) 200, 312.5 & 400 µmol L−1 creatinine solution, and
the greatest capacity (24452 µg g−1) in 625 µmol L−1 creatinine solution. From this
figure, we can tell that the higher creatinine solution concentration, the higher 940’s
adsorption level.
4.3.5 Creatinine adsorption capacity of zeolite-PAN membranes in
a flow state
All the membranes used in this experiment were electrospun for 1 h at a flow rate of
1 ml h−1. To test the creatinine adsorption capacity of PAN-zeolite membranes, the
membranes were cut into 10 mm disks and then mounted in syringe filter cartridges. A
solution of 200 µmol L−1 creatinine was filtered through the membrane at a rate of 1
ml h−1 for 3 h. Figure 4.10(a) reveals that the membranes with 840-NHA or 940-HOA
zeolites could successfully adsorb creatinine at distinct levels. Among the membranes
with 840-NHA, the membrane with 25 wt% zeolites (10-25) reduced as much as 43%
creatinine in 3 h. Similarly, within all the membranes with 940-HOA, 10-30 reduced
52% of the creatinine in solution. Figure 4.10(b) presents the creatinine adsorption
capacity of each membrane by membrane mass as well as zeolite mass. Similarly, 10-
25 membranes with 840-NHA and 10-30 membranes with 940-HOA both showed the
highest creatinine adsorption capacity by membrane mass: 2545 µg g−1 and 2658 µg g−1
respectively. Figure 4.10(b) demonstrates that the membrane with 10 wt% zeolite had
the highest creatinine adsorption value by zeolite mass (19117 µg g−1 for 840-NHA and
14140 µg g−1 for 940-HOA). A potential reason was that the zeolite distribution was
more uniform and less aggregated inside the membrane at low zeolite level, as supported
by Figure 4.5.
By collecting the membranes over different spinning times while keeping all the
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Figure 4.10: Creatinine adsorption capacity of membranes with different concentration of
840-NHA and 940-HOA under flow state in 200 µmol L−1 creatinine solution for 3 h. The
absorbance value of creatinine solution and the creatinine adsorption percentage was shown in
(a); Creatinine adsorption capacity of zeolites by fiber mass and zeolite mass were presented in
(b).
Figure 4.11: Creatinine adsorption capacity of membrane with 30 wt% 940 zeolite with various
thickness under flow state in 200 µmol L−1 creatinine solution for 3 h. The absorbance value of
creatinine solution and the creatinine absorption percentage (a); Creatinine adsorption capacity
of zeolites by membrane and zeolite mass (b).
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other experimental factors the same, we could get membranes with various thicknesses.
Figure 4.11 shows the creatinine adsorption capacity of membranes with various thick-
nesses. It shows that, the thinner the membrane, the higher the creatinine adsorption
capacity by membrane mass and zeolite mass. The membranes collected for 0.5 h at a
flow rate of 1 ml h−1 is recommended, since it had good creatinine absorption capacity
as well as the potential for high mechanical strength. Creatinine concentration for a
healthy person is normally less than 106 µmol, while that of patients with kidney disease
is around 1204 407 µmol. The creatinine adsorption capacity of 940-HOA increased
from 2262 µg g−1 in 50 µmol L−1 creatinine solution to 25423 µg g−1 in 625 µg L−1
creatinine solution. We can expect better creatinine adsorption capacity of 940-HOA
in solutions with higher creatinine concentration. Furthermore, the adsorption speed of
940-HOA is very quick (0.025 g 940-HOA will eliminate 91% of 20 µmol creatinine in
5 min). When we compared the creatinine adsorption capacity of zeolite powder and
that of zeolite incorporated in membranes, zeolite showed improved capacity inside the
membrane. Specifically, the creatinine adsorption capacity was 3733 µg g−1 for 840
powders while it was 19230 µg g−1 for 840 inside the membrane. On the other hand,
the capacity of 940-HOA powders was 8823 µg g−1 while it was 13574 µg g−1 for 940
inside the membrane. The fact that 840 and 940 zeolites had improved capacity inside
the membranes might be because of the following two reasons. First, the zeolites par-
ticles tended to coagulate even though they were shaken at 165 rpm during test since
there is no force to separate zeolites particles. However, they were better distributed
in the polymer matrix after stirring overnight. As a result, the effective surface area of
zeolites to adsorb creatinine was largely increased in the membranes. The second reason
is related to the testing method. The adsorption capacity of zeolite powder was tested
inside vials by shaking them at 165 rpm. And the composite membrane was tested in
flow state.
We also noticed that the creatinine adsorption capacity of 840 in membrane improved
four times compared with that of 840 powders while that of 940-HOA improved merely
0.5 times in the membrane when comparing with 940 powder. This is possibly because
the mean particle size of 840-NHA was 2 µm while that of 940-HOA was 0.67 µm.
840-NHA powders had significantly larger particle diameters when compared with the
PAN fiber diameters (277-410 nm), so a lower percentage of zeolite particle surface
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was blocked by fibers. On the other hand, 940 had closer particle size to the PAN
fiber diameters (276-398 nm), thus 940 zeolite powders can be buried inside the zeolites
easily. Future work will investigate how the particle size of zeolite affects the adsorption
capacity of PAN-zeolite membranes as well as explore the possibility of using PAN-
zeolite to eliminate creatinine from blood.
4.4 Conclusion
In summary, in this chapter we have successfully 1) identified 940 and 840 zeolite as
excellent uremic adsorption adsorbents; 2) fabricated PAN-zeolite nanofibrous mem-
branes through an electrospinning process; 3) compared creatinine adsorption capacity
of zeolites as free powders to that of zeolites incorporated into membranes.
The results showed that PAN-zeolite membranes are promising hemodialysis mem-
branes, since they can adsorb water-soluble toxins at a fast speed. These membranes
proved able to eliminate toxins through adsorption which is an excellent result. Together
with diffusion and convection mechanisms, we can expect these membranes to perform
better as hemodialysis membranes. The quick adsorption speed can also potentially
reduce the hemodialysis time needed for hemodialysis.
Furthermore, by comparing the creatinine adsorption capacity of 840-NHA and 940-
HOA, we noticed that the particle size and the surface area play an important role in
determining the adsorption capacity of the membranes. In next chapter, we carry out an
study to determine how the particle size and shape affects the membranes’ adsorption.
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Chapter 5
Effect of size and shape on
zeolite adsorption
In this chapter, we study how do the size and shape of zeolites affect their adsorption
when incorporated inside fibrous membranes. Our goal is to obtain an insight on how
to choose zeolites.
5.1 Introduction
Previous studies showed that zeolite and active carbon can be used as uremic toxins
adsorption materials. More specifically, MFI-type zeolites eliminated 85% of p-cresol in
the pathologic uremic concentration range [134]. 940-HOA and 840 NHA zeolite had a
200 µmol g−1 creatinine adsorption capacity in 200 µmol g−1 creatinine solution [133].
Activated carbon was used to adsorb uremic toxins such as creatinine, p-cresylsulfate,
indoxyl sulfate and hippuric acid [135, 21]. Na-STI (stilbite) was used to adsorb urea
while Ca-STI, K-STI and Na-STI displayed the ability to adsorb urea acid [23].
In Chapter 4 [136], we found that PAN-zeolite fibrous membranes can adsorb uremic
toxins. We also found that zeolites with different molecular structures have different
adsorption capacity. Zeolite particle size was an important factor which affected the
creatinine uptake ability when incorporated inside the membranes. Despite evidence
that zeolite particle size and shape matters on its adsorption ability as powders and as
fillers, this has not yet been investigated in detail [137].
To compare uremic toxin uptake of zeolites with different particle sizes and shapes,
three types of zeolite from the ZSM-5 group were chosen. Besides comparing their cre-
atinine uptake ability as powders, zeolites were also incorporated into polyacrylonitrile
(PAN) polymeric nanofibers that formed composite membranes [137, 111]. The PAN fi-
brous membranes are good candidates for hemodialysis membranes since they have high
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porosity, fine fiber diameters, large surface area-to-volume ratio, good interconnected
pore structures and high permeability [116, 138]. The PAN polymer also has a variety
of excellent characteristics including good thermal and mechanical stability, tolerance to
bacteria and photo irradiation [139], and excellent membrane forming properties [117].
Creatinine is the most common molecule used in studies to represent uremic toxins.
It is one type of uremic toxin and it is produced by the breakdown of creatine phosphate
in muscles. Free creatinine concentration in the blood of healthy persons is relatively
low, around 106 µmol, but can reach up to 1204 ± 407 µmol in cases of renal failure
[23]. For this reason, creatinine is also used in this chapter as a representative uremic
toxin.
The aim of this chapter is to examine how do particle size and shape affect creatinine
uptake by ZSM-5 zeolites. First, we study the creatinine uptake ability of spherical mi-
croparticle 840, spherical nanoparticle P-87 and rod-like nanoparticle P-371 zeolites in
creatinine solutions. Their creatinine uptake levels are measured in creatinine solutions
with different concentrations, volumes and adsorption times. Then, we incorporate the
three zeolites inside their respective nanofibrous membranes and measure their creati-
nine uptake abilities. Finally, the creatinine uptake ability by zeolites in membrane is
compared with that of their respective powders’.
5.2 Sample preparation
5.2.1 Materials
Polyacrylonitrile (PAN) with molecular weight of 150,000, dimethylformamide (DMF)
and creatinine were purchased from Sigma Aldrich, Co. HSZ-series zeolite 840-NHA
(ZSM-5) powders were purchased from Tosoh. Nano ZSM-5 P-87 and P-371 were pur-
chased from ACS Materials, LLC. Ultrapure water was also used.
5.2.2 Preparation of PAN-zeolite composite membranes
A 10 wt% PAN solution was made first by dissolving PAN powders in DMF and stir-
ring overnight at room temperature. PAN-zeolite composite solutions were prepared by
adding zeolite powders into the 10 wt% PAN solutions. The composite solutions were
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stirred overnight again and ultrasonicated for 1 h during the stirring process. PAN-
zeolite composite solutions of 840, P-87, and P-371 were prepared with zeolite to PAN
ratio of 3: 10. PAN-zeolite composite membranes were fabricated using self-built electro-
spinning equipment. The voltage, feed rate, tip to collector distance, relative humidity
and temperature were set as 22.5 kV, 1 ml h−1, 15 cm, 10% and 22 ◦C respectively.
5.2.3 Measurement
Dynamic light scattering (DLS)
A dynamic light scattering (DLS), Zetasizer Nano ZS (Malvern) was used to analyze the
particle size distribution of the zeolite powders. The powders were dissolved in water
at a concentration of 8.6 g L−1 and all samples were tested three times.
Adsorption studies of zeolite powders
Creatinine adsorption capacity of three zeolites with different size and shape was tested
by the following procedure. To test the effect of the creatinine concentration on zeolites’
adsorption capacity; 0.025 g 840, P-87, and P-371 powders were respectively added into
vials with 10 ml 50, 200, 400, and 625 µmol L−1 creatinine solutions. The vials were
shaken at a speed of 165 rpm at 37 ◦C for 3 h in a shaker (C25, New Brunswick Sci-
entific, USA). To evaluate the creatinine solutions’ volume effect on zeolites’ creatinine
adsorption capacity; 0.025 g 840, P-87, and P-371 powders were added into 3 ml, 6 ml,
10 ml, and 18 ml 400 µmol L−1 creatinine solution and shaken for 3 h at the same con-
ditions as above. Finally, the effect of adsorption time on zeolites’ creatinine adsorption
capacity was measured; 0.025 g 840, P-87, and P-371 powders were added into 10 ml
400 µmol L−1 creatinine solution and were shaken for 5 min, 10 min, 15 min, 20 min,
1 h, and 3 h at the same condition as above. All the experiments were repeated three
times. A UV-Visible spectrophotometer (Ultraspec 2100 pro) was used to measure the
absorbance of the creatinine solution. A UV calibration standard line for creatinine in
ultrapure water was prepared based on the absorption value of creatinine solution at
234 nm. Solutions with concentration of 50, 100, 150, 200 and 250 µmol L−1 were tested
for drawing the UV calibration standard line.
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Adsorption studies of PAN-zeolite composite membranes
The creatinine adsorption capacity of different composite membranes were tested in a
flow state according to the following procedure. First, circular composite membranes
with a diameter of 10 mm were cut and positioned in a syringe filter cartridge (EMD
Millipore, CA). Then, a 400 µmol L−1 creatinine solution was introduced into the inlet
of the cartridge to flow through the membrane and exit through the outlet at a flow
rate of 1 ml h−1 for 3 h. Finally, UV absorption spectra of solutions collected from the
outlet were measured. Three samples of each type of membrane (30 wt% of 840, P-87
and P-371) were tested.
5.3 Results and discussion
5.3.1 Zeolite powder analysis
The SEM images and particle size distribution of the three zeolite particles used in this
paper are shown in Figure 5.1. The framework is ZSM-5 and they all have relatively
uniform particle sizes. 840 zeolite particles (Figure 5.1(a,d)) are relatively spherical with
an average particle diameter of 1849 nm, while P-87 zeolite particles (Figure 5.1(b,d))
are also spherical with an average particle diameter of 578 nm. P-371 zeolite particles
(Figure 5.1(c,d) are rods with particle size of 300 700 nm. Figure 5.1(d) shows the
average particle size of the three zeolites, as measured by DLS. From Figure 5.1 we can
confirm that 840 and P-87 zeolites have difference in particle size, while P-87 and P-371
zeolites have different shapes.
5.3.2 Fabrication of PAN and PAN-zeolite composite membranes
Electrospinning is a simple and effective way to make porous membranes which can be
used in water treatment, bacterial and particle filtration and dialysis. In this paper, PAN
nanofibrous membranes as well as PAN-zeolite composite membranes were fabricated by
adjusting important influence factors such as voltage, feed rate, tip-to collector distance
and humidity. The best electrospinning conditions were found to be voltage of 22.5
kV, feed rate at 1 ml h−1, distance of 15 cm, and humidity of 10%, respectively. The
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Figure 5.1: SEM images of zeolite particles and their average particle size. 840 (a), P-87 (b),
P-371 (c) and particle size distribution.
morphology of PAN membranes and PAN-zeolite composite membranes are shown in
Figure 5.2. Figure 5.2(a) shows a membrane with 10 wt% PAN. Smooth fibers with
rare beading can be observed in the SEM image. The average diameter of the fibers is
9 nm (Figure 5.2(b)), which is the thinnest among the four samples. After zeolites were
incorporated into the membrane, the edge of the fiber is coarser. We can see zeolite
particles attached along with the fiber, as indicated by Figure 5.2(c,e,g). The reason
is that zeolite particles can appear on the surface of the fiber, partially in the fiber or
completely within the fiber, which disturbs the smooth fiber morphology. When we
compare the average diameter of fibers with different zeolite particles, we observe that
the composite membrane with microparticle 840 zeolite (Figure 5.2(c,d)) has the thickest
fiber diameter, at 286 nm. The membrane with P-371 zeolite has an average diameter
of 280 nm (Figure 5.2(h)) while the membrane with P-87 has an average diameter of
257 nm (Figure 5.2(f)). From Figure 5.2 we can see that the membrane presented an
increased fiber diameter after zeolite was incorporated. The increase was relevant to
zeolite particle size.
EDX test shows the atomic distribution in the image. Silicon (Si) atoms were chosen
to represent zeolite distribution since in our samples it could only be found in zeolites.
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Figure 5.2: SEM images of electrospun PAN and PAN-zeolite membranes as well as their fiber
diameter distributions. PAN (a,b), PAN-840 (c,d), PAN-P87 (e,f) and PAN-P371 (g,h). (PAN
is 10 wt % and all the zeolites are 30 wt %)
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Figure 5.3: SEM and EDX mapping images of PAN-zeolite membranes: PAN-840 (a) with
Si-mapping (b), PAN-P87 (c) with Si-mapping (d) and PAN-P371( e) with Si-mapping (f).
Figure 5.3 is the SEM/EDX mapping images of composite membranes with 840, P-87
and P-371 zeolites. Figure 5.3 (b,d,f) shows that the Si atoms are mostly distributed
along the fiber, relatively uniform.. Some large areas of Si aggregation were observed
in Figure 5.3(c) and mild aggregation also existed in Figure 5.3(e). We believe that
aggregation occurs for particles that cannot be easily separated. Even though all three
particles were stirred with the same process, we can see that nanoparticles are harder
to distribute evenly when compared with micro-particles.
The TGA test further showed the precise weight percentage of zeolites inside the
membranes, as indicated in Figure 5.4. The weights of the membranes are considered
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as 100 wt% at room temperature and they gradually decreased due to the combustion
of PAN polymers as the temperature goes up. We can see that all the PAN were fully
combusted when the temperature reached 700 C. There is zero weight left in pure PAN
membrane when the temperature was above 700 C, as indicated in Figure 5.4 (a). For
the other three types of composite membranes fed with 30 wt% 840, P-87 and P-371
zeolites, they had respectively 22.5 wt%, 22.5 wt% and 22.5 wt% zeolites left, as shown
in Figure 5.4(b, c, and d). The data indicates that the difference between the percentage
of zeolite in feed and zeolite in membrane was 25%.
5.3.3 Creatinine adsorption capacity of zeolites
Investigating the adsorption behavior of zeolite powders provides guidance to maximize
the creatinine uptake by zeolites. Here we studied how the creatinine concentration,
creatinine solution volume, and adsorption time affected zeolites’ creatinine adsorption
ability.
All three types of zeolite showed gradually improved creatinine uptake in creati-
nine solutions with increased concentration from 50 µmol L−1 to 625 µmol L−1. To be
specific, the creatinine uptake level of 840, P-87 and P-371 zeolite powders were 1410,
1625, and 1853 µg g−1 in 50 µmol L−1 creatinine solution, and they improved to 10511,
10820, 10443 µg g−1 in 625 µmol L−1 creatinine solution, respectively (as shown in
Figure 5.5 (a)). This indicated that all three zeolites had a higher creatinine uptake
ability in creatinine solution with higher concentrations. When we compared the crea-
tinine adsorption levels of 840, P-87 and P-371 at each concentration, they showed very
similar result. Thus, the particle size and particle shape barely influences the creatinine
adsorption level of the three zeolite powders if the creatinine concentrations is kept the
same.
Figure 5.5(b) further shows creatinine uptake level of 840, P-87 and P-371 zeolite
powders in 400 µmol L−1 creatinine solution with increased volume (3, 6, 10, 18 ml).
All three zeolites showed improved creatinine uptake level with increased creatinine
volume. However, they had different rates of increase. The creatinine uptake level
of 840 zeolite in 18 ml creatinine solution was 2.8 times of that in 3 ml creatinine
solution, with creatinine uptake levels maximized at 18 ml. The creatinine uptake level
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Figure 5.4: TGA analysis of membranes: pure PAN (a), PAN with 840 (b), PAN with P-87
(c) and PAN with P-371 (d).
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of P-87 and P-371 zeolite powders improved 1.9 and 1.8 times respectively in an 18 ml
creatinine solution compared to a 3 ml creatinine solution. However, they both reached
maximum creatinine uptake in 6 ml creatinine solution. When we compared 840 with P-
87 zeolite powders, 840, which has larger particle size, presented better performance on
adsorbing creatinine. However, when we compared P-87 with P-371 zeolite powders, the
performance was similar despite their different particle shapes. Thus, zeolite particles
with larger particle size had higher creatinine adsorption, while particles with different
shapes presented no difference along with increased creatinine volume.
Figure 5.5(c) shows the effects of adsorption time on the creatinine adsorption ca-
pacity of the zeolites in 10 ml 400 µmol L−1 creatinine solution. The figure showed
that all three zeolites reached the maximum creatinine uptake level at 30 min. Besides,
comparing the creatinine adsorption level of 840, P-87 and P-371 zeolite powders at
each time interval (2 min-3 h), we saw very similar levels, except that of P-371, which
was very low at 2 min. Thus, the particle size and particle shape barely influence the
creatinine adsorption level of the three zeolite powders at different adsorption time. Fur-
thermore, the figure shows that the three zeolites have a creatinine uptake of 5500 µg
g−1 in 5 min, this indicates that the adsorption speed of zeolites is fast when comparing
with hemodialysis membranes, which is normally 3 h [139].
5.3.4 Comparison of zeolite particle effects
The investigation of zeolite powders showed that zeolite shape had no effect on its
creatinine adsorption level at various conditions. Similarly, the size had no effect on the
adsorption level in creatinine solution with different concentrations or adsorption time
except in solution with different volumes. However, the particle size and shape both
had significant effects on zeolite’s creatinine uptake level when they were incorporated
inside membranes. Figure 5.6 shows the comparison of creatinine adsorption level of
zeolites as filler in the membranes and as powders. Same amount of zeolite powder was
measured for adsorption experiment after calculating the relative mass of zeolites inside
their membranes. 840 in the membrane had a creatinine adsorption capacity as high as
8957 g g−1 , which is half of that of 840 as powders. P-87 inside the membrane had much
lower creatinine adsorption capacity when compared with that of P-87 powders. On the
66
Figure 5.5: Study of the relationship of zeolite powders’ adsorption capacity of creatinine with
creatinine concentration (a), solution volume (b), and adsorption time (c).
other hand, P-371 showed the most decreased creatinine adsorption capacity inside the
membrane when comparing with that of its powders. The adsorption capacity of zeolites
showed various level of decreased inside the membranes because the fiber blocked parts
of the surface of zeolites. However, the results showed that micro-840 in the membranes
kept approximately half of its capacity as free powders, while nano-size P87 lost almost
3 quarters of its capacity compared with its powder and P-371 lost an even higher
percentage of its capacity. The size and shape of zeolites has an important effect on
their creatinine adsorption capacity when incorporated inside the membranes.
Micro-particle 840 in membranes had much higher creatinine adsorption level than
that of nanoparticle P-87 in the membrane. The reason is that when zeolites were incor-
porated in the membranes, the PAN nanofibers which had an average diameter of 9 nm,
tended to block parts of surface area of zeolites powders. The polymer fiber blocked
a relatively smaller percentage of microparticle 840 since there is a nearly nine-fold
size difference between particles and PAN fiber. So the unblocked functional surface
area of microparticles was larger than nanoparticles, which had roughly threefold par-
ticle size difference with the diameter of PAN fibers. As a result, microparticle zeolite
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Figure 5.6: Comparison of creatinine adsorption capacity of 840, P-87 and P-371 zeolite in
membranes (by membrane mass and zeolite mass) and as powders.
(840) in membranes showed higher creatinine adsorption capacity when compared with
membranes with nanoparticle zeolites (P-87).
Spherical particle P-87 zeolite in membrane had higher creatinine adsorption level
than rod particle P-371 zeolite in membrane. The possible reason is that when the
composite fiber is formed in the electrical field, the rods tend to align with the fiber.
The rod is 300 nm on one dimension, which is very similar to the fiber diameter, thus,
it can easily get buried inside the fiber. As a result, a large percentage of its surface
is blocked by PAN fiber.The unblocked functional particle area is relatively small when
compared with spherical particles, which had particle sizes close to the fiber diameter.
5.4 Conclusion
In this chapter, we studied the influence of zeolite size and shape on the performance
of PAN-zeolite membranes with respect of creatinine uptake level. We first measured
spherical microparticle 840, spherical nanoparticle P-87 and rod-like nanoparticle P-
371 zeolites as powders in creatinine solution with different concentrations, volumes
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and adsorption time. These particles showed similar creatinine uptake ability. Then,
nanofibrous membranes with these zeolites were electrospun and their ability to adsorb
creatinine was measured and compared. Zeolites had significantly different creatinine
uptake ability after being incorporated inside the membranes. Spherical microparticle
840 in the membrane presented the best creatinine uptake ability, at 8957 µg g−1, which
was half of its powders’. On the other hand, P-87 presented largely decreased, while
P-371 presented even lower creatinine uptake ability in membranes when compared to
respective powders’.
We proved that the size and shape of zeolites have a significant effect on their
creatinine adsorption level in the membranes. Microparticles have better adsorption
capacity than nanoparticles when incorporated inside the membranes although the size
does not have any effect on zeolite powders. The spherical nanoparticle shape is a better
choice than rod nanoparticles when incorporated in the polymer fiber made through
electrospinning. This finding can provide guidance for choosing the right size and shape







In the previous two chapters, we used an electrospinning method to fabricate composite
membranes and we proved that these membranes are able to to adsorb water-soluble
toxins. Dialysis membranes should have pore sizes larger than 5 nm in order to remove
large molecular uremic toxins and smaller than 8 nm in order to prevent the leaking of
albumin. SEM images of our electrospun membranes, however, showed that the pore size
of our membranes is around 5 micrometers, making them unsuitable for hemodialysis.
In this chapter, we adopt a spin-coating method with the goal of fabricating composite
membranes that fulfil the requirements of hemodialysis. In order to understand the
adsorption mechanism of zeolites we study pH and salts’ effect on zeolite’s adsorption
and desorption.
6.1 Introduction
Current hemodialysis helps patients to clear uremic toxins mainly through a hollow fiber
dialyzer. These toxins are cleared through diffusion due to the gradient difference in
blood and dialyzate[140]. While diffusion methods are excellent at clearing water-soluble
toxins, other types of important toxins, such as protein-bound toxins, are ignored. A
more promising way to clear toxins is through adsorption of toxins by sorbents since
they can both adsorb water-soluble toxins and protein-bound toxins [23, 141, 142].
Sorbents have been used in hemodialysis for the past three decades [142, 143]. They
can be used to regenerate dialyzate [144, 145, 146, 147, 148, 149], which greatly reduces
the amount of dialyzate needed during hemodialysis and makes portable hemodialysis
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possible. Activated carbon [21], charcoal [141] and zeolites [136] are excellent adsor-
bents for uremic toxins. Zeolites in particular are the most promising adsorbents for
hemodialysis because they can specifically adsorb uremic toxins without affecting other
biological molecules in blood [53]. Wernert’s [23, 139] research showed that zeolite par-
ticles can successfully remove water-soluble uremic toxins and p-cresol. Sorbent mem-
branes [141, 142, 21, 150] also proved able to reduce uremic toxins and are promising
membranes for hemodialysis.
In previous two chapters [136], we fabricated zeolite-polyacrylonitrile nanofiber mem-
branes through an electrospinning method and these membranes presented fast and good
creatinine adsorption ability. The drawback of our nanofiber membranes is that their
pore size is too large for hemodialysis, making them unable to effectively prevent the
leakage of albumin into dialyzate.
In order to fabricate composite membranes that are suitable for hemodialysis, a
spin-coating method is proposed in this chapter. Spin-coating is an effective and easy
method to make membranes. Nie [98] proved that spin-coating can be used to make
hemodialysis membranes. Polyethersulfone (PES) polymer was chosen as the polymer
to incorporate zeolite since it is commercially available and has been currently used as
hemodialysis membranes in clinic [151]. Another advantage of PES polymer is that it
can be used to make porous membranes through spin-coating in the lab. The spin-
coating set-up is uncomplicated and the process is repeatable. It can also be used to
make other composite membranes [98, 6].
In this chapter, we fabricate three types of zeolite membranes through a spin-coating
process, then we test and compare their adsorption ability for creatinine. We also study
the effect of pH and salt on P87 zeolite powders’ creatinine adsorption properties in
order to deduce the mechanism through which P87 adsorbs creatinine.
6.2 Sample preparation
6.2.1 Materials
Commercial Ultrason E 6020 PES was obtained from BASF, Co (U.S.) and used as re-
ceived. Dimethylacetamide (DMAC) and creatinine were purchased from Sigma Aldrich,
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Co. HSZ-series zeolites 840-NHA was purchased from Tosoh. P-87 and P-371 were pur-
chased from ACS Materials, LLC. 1.5 inch by 1.5 inch glass slides were cut by laser from
microscope slides, which is from Ted Pella, Inc. Ultrapure water was also used. NaCl,
KCl and CaCl2 were purchased from Fisher Scientific, Co.
6.2.2 Sample fabrication
Composite membranes of PES-zeolite were prepared through spin-coating followed by
liquid-liquid phase separation in water. A typical process is as follows: an 18 wt% PES
solution was first made by dissolving PES flakes in DMAC and it was stirred overnight
at room temperature. Then, 0.48 g zeolite was added into 8 g of pre-made PES solution
and stirred overnight to obtain a composite solution. The composite solution was then
dripped on a glass substrate and spin-coated at 400 rpm with an acceleration of 4 for
60 s. The glass slides with flatted composite solutions were immersed in distilled water
immediately and membranes were formed in the water shortly. By this method, PES
membranes with 50 wt% of 840, P-87 and P-371 were synthesized. Pure PES membranes
were also synthesized by the same procedure and used as control.
6.2.3 Measurements
Thermal gravimetric analysis (TGA)
A Q500 TGA instrument from TA Instruments was used to carry out thermal gravi-
metric analysis for all the samples. The temperature scans were taken from room tem-
perature to 800 ◦C with a heating rate of 10 ◦C min−1 and at an ambient atmosphere
with a flow of 20 ml min−1.
Water flux
The water flux of the spin-coated composite membranes was measured using a 10 ml
ultrafiltration cell from Millipore. The effective membrane area is 4.1 cm2. The system
was steadied with water for 20 min at 11 psi to compact the membranes. Then, the
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where m is the quality of the permeated water (g); S is the effective membrane area
(m2); P is the pressure (hmmHg) and t is the permeated time (h).
Creatinine adsorption study
The creatinine adsorption study of fabricated pure PES membranes and PES membranes
with 50 wt% of 840, P371, P-87 zeolites was tested in 0.1 mg/mL creatinine solutions.
All these membranes were spin-coated at a speed of 400 rpm with an acceleration of 4
for 1 min on the 1 inch by 1 inch glass substrates. A piece of each type of membranes
was weighed and immersed in a 6 ml creatinine solution and stirred at 37 ◦C for 3 h.
Accordingly, the actual amount of zeolite contained by each membrane was calculated by
using the TGA data. Then, the corresponding weight of zeolite powders was measured
and the creatinine adsorption rate of these powders was also studied through the same
procedure as the membranes. All the experiments were repeated three times. The
creatinine concentration was determined by a UV-visible spectrophotometer at 235 nm
with a 1 mm quartz cuvette at room temperature. The adsorption level of the membrane
was expressed as µg creatinine per g of membrane and µg creatinine per g zeolite in
the membrane. Similarly, the adsorption level of zeolite powder was expressed as µg
creatinine per g zeolite.
Effect of pH and salts on creatinine adsorption by zeolite
To evaluate whether pH and salt affect P87’s adsorption level, the following experiments
were carried out. The influence of salt and pH on creatinine’s UV intensity were mea-
sured and set as control. First, a 0.1 mg ml−1 creatinine solution was made. Then, 500
µl 0.1 mg ml−1 creatinine solution were mixed with 500 µl water, NaCl , KCl CaCl2
and pH 4 to pH 9 PBS buffer. We piped 500 µl of these mixed solutions and added
each of them to 1.5 ml PBS before measuring their UV-vis intensity.
Adsorption tests in salt and pH medium were carried out by measuring 0.01 g P87
zeolite and placed them into centrifuge tubes with 500 µl 0.1 mg ml−1 l creatinine
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solutions. Then, 500 µl water, NaCl , KCl, CaCl2 and pH 4 to pH 9 PBS buffer were
added into each centrifuge tube and incubated for 30 min. They were centrifuged at
15000 rpm and 500 µl supernatant was mixed with 1.5 ml PBS before measurement by
UV-vis spectrometer.
Effect of pH and salts on creatinine desorption by zeolite
In order to evaluate how pH and salt affect P87’s creatinine desorption, 0.01 g P87
zeolite was measured and placed into the centrifuge tubes with 1 ml of 0.1 mg ml−1
creatinine solutions. The mixture was centrifuged at 6000 rpm after 0.5 h incubation to
get precipitant. The precipitant was washed with 1.5 ml water to remove non-adsorbed
creatinine. Then, 1 ml water, NaCl , KCl, CaCl2 and pH 4 to pH 9 PBS buffers were
added into precipitant and mixed well. They were further incubated for 0.5 h before
being centrifuged at 15000 rpm. Following this, 750 µl of supernatant was mixed with
1.25 ml PBS and UV-vis intensity was measured.
6.3 Results and discussion
6.3.1 Data presentation methods
In this chapter, the data related to water flux are presented in a table, the value is the
average of three repeated test.
The data related to adsorption test are presented through bar figures. In these
figures, the height of the bar is the average value and the error bar is the range of value.
The data are presented in this way to show the value range of these data.
The data related to pH and salts effects on adsorption are presented by fluorescence
images. In these images, C represents control groups, while the red line represents the
experiments data under different conditions. The data are presented in this way to
eliminate the potential pH/salts effects on indoxyl sulfate adsorption value.
The data related to pH and salts effects on adsorption are presented by fluorescence
images. Each line indicates the experiments data under different conditions.
75
6.3.2 Properties of membranes
Figure 6.1 shows the cross-section of PES and PES-zeolite composite membranes. The
figure presents the morphology and structure of the membranes as well as the distribu-
tion of zeolites. Clear and smooth channels were observed in pristine PES membranes,
as Figure 6.1(a) shows. Large channels with diameter of 5 µm are present in the mem-
branes. We can also observe 100-200 nm pores on the inner surface of membranes that
consisted of membranes channels, as shown in Figure 6.1(b). Figure 6.1(a, b) indicated
that PES membranes, while displaying a high internal porosity, presented smooth outer
surfaces. As a result, it should be difficult for water to permeate through the mem-
branes. Indeed, water flux experiments confirmed that the average water flux for pure
PES membranes (shown in Table A.4) is merely 0.85 g/m2 h mmHg.
Figure 6.1(c.d) shows PES membranes with 50 wt% of 840 zeolites. The smooth and
clear channels observed in pristine PES membranes were clearly affected by incorporat-
ing of 840 zeolite. More irregular channels were observed caused by the coagulation
of 840 particles. The surface of the membranes is coarse, as shown in Figure 6.1(d).
Some round pores were formed with size below 100 nm due to the incorporation of 840
zeolites. Water flux of this membranes is 43.35 g/m2 h mmHg, which indicates that the
addition of zeolites into membranes can improve the pore connection.
Figure 6.1(e,f) shows PES membranes with 50 wt% of P87 zeolites. P87 are sphere
nanoparticles with diameter of 550 nm. They are smaller than 840 microparticles, which
have an average diameter of 1850 nm. As a result, They affect the inner structure of
their membranes differently. The channels are still regular and clear though the inner-
channel surface is no longer smooth when compared with that of pure PES. Similarly,
pores with sizes around 500-1000 nm were observed on the inner surface of this type of
membrane. Water flux of this membrane is 76.83 g/m2 h mmHg, a result in accordance
with the morphology and structure of P87 membranes, which have more small pores on
the surface of the membranes as well as regular pore channels.
Figure 6.1(g,h) shows PES membranes with 50 wt% of P371 zeolites. Due to the
rod-like shape of these zeolites, they tend to entangle among themselves. As such,
smeared pore channels were observed in Figure 6.1(g). Zeolite rod clusters were also
observed in Figure 6.1(h). Affected by these structural reasons, the water flux of this
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Figure 6.1: Cross-section SEM image of membranes: PES(a,b), PES-840(c,d), PES-P87(e,f)
and PES-P371(g,h).
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Table 6.1: Water flux of pure PES and composite PES-zeolite membranes.





Figure 6.2: TGA data of pure PES and composite PES-zeolite membranes
type of composite membrane is 58.15 g/m2 h mmHg.
Here, we know that the incorporating of zeolites into pristine membranes results
to membranes with different inner and surface structures. Furthermore, the structural
changes in the membranes are related to the size and shape of the zeolite, as also
indicated by nanofibrous membranes with these zeolites[152]. Finally, changes to the
membrane structure further affect membrane properties, such as water flux.
TGA data indicated (Figure 6.2) that membranes mass changed considerably as the
temperature increased from room temperature to 800 ◦C. For pure PES membranes,
around 5 wt% residual was left. For 840 and P87 and P371 membranes, around 50.8
wt%, 46.5 wt%, and 49.1 wt% residuals respectively were left. The result indicated
that the majority of zeolites from the composite solutions were incorporated into the
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Figure 6.3: Creatinine study of PES/ PES-zeolite membranes and zeolite powders.
membranes.
6.3.3 Creatinine adsorption
Creatinine has previously been used as a representative of water-soluble uremic toxins
[153, 133, 135], so it was also used in this paper. After we incorporated 50 wt% of these
three zeolites into the PES membranes, the creatinine adsorption levels of the compoiste
membranes were measured. Figure 6.4 shows that 840, P-87 and P-371 compoiste mem-
branes’ creatinine adsorption levels were 4948, 2532 and 1312.5 µg g−1 respectively. By
calculating the incorporated amount of zeolite in each types of membrane, we measured
the relative zeolites’ creatinine adsorption level as free powders. The results were 6787,
7880 and 5500 µg g−1. In general, the composite membranes had lower adsorption level
when compared with that of free powders. This is easy to understand, each gram of
composite membranes have around 0.5 g of PES and 0.5 g zeolite. PES has a very
low creatinine adsorption level, at 171 µg g−1. Even though all the membranes had
lower creatinine adsorption levels when compared with same weight of their powders,
840 membranes had 0.73 times of its powders’ adsorption ability, while P87 and P371
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sustained only 0.32 and 0.24 times of their powders’ adsorption levels. The difference is
related to the particle size and shape, as well as the difference in the membranes’ flow
channel, as show in SEM image. 840 zeolite are sphere microparticles with an average
diameters of 1840 nm. 87 zeolite are sphere nanoparticles with an average diameters of
550 nm. P371 are rod nanoparticles with average diameters of 300 ×700 nm. The larger
the particle size, the smaller percentage of surface will be blocked by PES matrix. We
observed similar result when we incorporated these three types of membranes within
nanofibrous membranes [152].
However, the adsorption level of zeolites in the membranes with 840 is the highest,
at 9896 µg g−1. It is even higher than its free powders. Meanwhile, P87 and P371
in membranes had lower adsorption levels when compared with their free powders.
Two possible factors contributed to the phenomenon. One factor is that PES matrix
blocks parts of zeolites surface. This prevents creatinine from entering some of the pore
channels. Another factor is that dispersing zeolites in membranes actually breaks soft
aggrations of zeolite powders and enables more surface exposed. The adsorption level is
the comprehensive result of these two forces. For 840 zeolite, microparticles, dispersing
factor plays a major role while for P87 and P371, nanoparticles, blocking factor plays a
major role.
6.3.4 pH and salts effect on adsorption
Figure 6.4 shows the pH effect on P87’s creatinine adsorption level. We tested the
adsorpton of 0.01 g of P87 in 0.25 mg ml−1 water based creatinine solution with pH
adjusted PBS buffer(pH 4 to 9). The control groups are the corresponding solutions
without zeolites. As the figure shows, acidic environments (pH 4 to 6) enhance P87
powders’ creatinine adsorption level while alkaline environments (pH 8 to 9) weaken it.
This difference happens because creatinine is already protonated at low pH. Since the
pKa value of creatinine is 5.02 [110], it is adsorbed into zeolite through ion exchange.
However, creatinine is neutral at pH 7 [154]. At this condition, it needs to diffuse to the
zeolite channels before being protonated in-site. When pH > 7, the alkaline environment
hinders the protonation of creatinine. Thus as the pH increases from 4 to 9, a gradual
decrease in creatinine adsorption level is observed.
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Figure 6.4: The effect of pH on P87’s adsorption level of creatinine.
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Figure 6.5: The effect of salts on P87’s adsorption level of creatinine.
When we compare the adsorption of creatinine in water and in PBS at neutral pH,
we observe that it has a higher adsorption level in water. With the presence of PBS,
P87 had a decreased adsorption level. This phenomena was also confirmed by Scha¨f
[110]. The reason is that PBS contains cations that will compete with the creatinine
for adsorption sites.
Figure 6.5 indicates how various salt solutions affect the adsorption of creatinine
for P87 zeolite particles. The slightly increased intensities of solution with the presence
of NaCl and KCl show that Na+ and K+ compete with the creatinine for adsorption
sites. However, in the presence of Ca2+ , P87 did not adsorb any creatinine. We can
predict that all the adsorption sites are occupied by Ca2+ cations, since it has double
the electric charge than protonated creatinine.
6.3.5 pH and salts effect on desorption
After the creatinine was absorbed onto zeolites formed as conjugates, PBS buffer with
pH from 4 to 9 and different salt solutions (NaCl, KCl and CaCl2) were added to the
conjugates in order to study the desorption of creatinine under these mediums. Figure
6.6 further confirms that the presence of Ca2+ will replace all the protonated creatinine
in the zeolite channels. K+ and Na+ only partially replace adsorbed creatinine. At the
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Figure 6.6: Salt’s and pH effect on P87’s desorption of creatinine.
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Figure 6.7: Illustration of P87 adsorbs creatinine in acidic and alkaline environment
same time, we can see that the adsorbed creatinine is quite stable in water since only a
very small portion of them desorbed.
Figure 6.6 clearly shows that at lower pH (4-6), the protonated creatinine is stable
inside the zeolite, while neutral and alkaline environment will reverse creatinine’s pro-
tonated process, thus it will be desorbed from the adsorption site in the zeolite. The
more alkaline, the higher percentage of creatinine was desorbed from the zeolite. The
mechanism is illustrated in Figure 6.7.
6.4 Conclusion
Spin-coating is a simple and effective method to fabricate membranes. In this chapter,
polyethersulphone-zeolite membranes were made through a simple spin-coating process
and evaluated for creatinine adsorption. SEM images showed that the incorporation of
zeolite into the membranes affected their pore channels. The water flux was also affected.
Creatinine adsorption tests showed that the membranes with 840 could adsorb 4948 µg
creatinine per g membranes.
In order to infer the membranes’ adsorption mechanism, we also studied the effects
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of pH and salts on zeolite’s adsorption and desorption of creatinine. We found that
acidic environments enhance zeolite’s creatinine adsorption while alkaline environments
weaken it. We predict that creatinine needs to be protonated before adsorbed onto
porous zeolites. The acidic environment helps to protonate creatinine, while alkaline
environment hinders this process. The existence of various cations also decreases ze-
olite’s creatinine adsorption. The reason is that cations will compete with creatinine
for the adsorption sites in zeolites. The study of the effects of pH and salts on zeolites
adsorption of creatinine provided insights into its adsorption mechanism.
In summary, we successfully fabricated a membrane with suitable pore size that









In the previous chapter, we fabricated PES-zeolite membranes with suitable pore size
for hemohemodialysis. We also studied their ability and mechanism to eliminate water-
soluble toxins. It was still unclear, however, whether they could adsorb protein-bond
toxins, and through which mechanism. In this chapter we answer both of these questions.
7.1 Introduction
Kidney function impairment leads to a progressive retention of a large number of com-
pounds which are normally excreted via the urinary tract [155, 156]. These compounds
are called uremic toxins and they can be classified into three groups according to
their molecular weight and protein-bonding ability[157]: (1) small molecular weight
water-soluble compounds; (2) protein-bound compounds and (3) middle molecules [158].
Protein-bound solutes are generally ignored, as hemodialysis adequacy is traditionally
measured by urea removal. Hemodialysis can only eliminate 30% of protein-bound tox-
ins due to their binding to albumin, while it can clear 60% of urea and creatinine [159].
In modern dialyzers and hemodialysis prescription, protein-bound solutes are poorly
cleared [160].
Toxic effects appear to be caused by compounds that are difficult to be removed
through hemodialysis. This is particularly true for protein-bound compounds. Increas-
ing experimental and clinical evidence [161] support the hypothesis that uremic tox-
ins, especially protein-bound toxins, are not only related in the progression of chronic
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kidney disease(CKD) [162, 163], but also in the advancement of cardiovascular disease
[164, 163]. Two protein-bound compounds, indoxyl sulfate and p-cresyl sulfate, are nor-
mally chosen as protein-bound toxin prototypes in research. These two proteins have
shown to exert toxin effects in vitro [165]. Results with CKD patients also identified
these two proteins as emerging mortality risk factors [164, 166, 161].
Vanhoder[167] performed a systematic review on biologic effects of protein-bound
uremic retention solutes. The studies showed that most functional deterioration were
linked to uremic cardiovascular disease and kidney damage, and it seems to confirm the
toxicity of indoxyl and p-cresyl sulfate and support their roles in vascular and renal
disease progression.
Clinical studies also showed that individuals with chronic kidney disease are at an
extremely high risk of cardiovascular disease [168] and this is caused by protein-bound
toxins. In hemodialysis patients, serum concentrations of indoxyl sulfate and p-cresyl
sulfate are approximately 54 and 17 times higher, respectively, than the corresponding
concentrations in healthy subjects. Serum indoxyl sulfate levels have been shown to
associate with vascular calcifications [169]. P-cresyl sulfate also seems to be associated
with cardiovascular mortality in patients with chronic kidney disease [170, 28, 164,
166]. More than 50% of deaths in CKD stage 5 are due to cardiovascular disease [171].
Hemodialysis patients with chronic kidney disease had approximately 10-20 times more
frequent cardiovascular death than healthy individuals [172].
Methods are developed to reduce the level of protein-bound solutes include modify-
ing the hemodialysis procedures (increase KoA and Qd) to enhance their clearance [173],
using sorbents [149], or limiting their production [15]. Among these method, adsorp-
tion of protein bound toxins onto porous particles is promising [6, 135, 21, 23, 139]. By
incorporating adsorbents into hemodialysis membranes, we seek to clear protein-bound
toxins through adsorption.
In this chapter, we propose a new generation of innovative hemodialysis membranes
that have a high clearance level for protein-bound toxins. In order to achieve this, we
fabricated PES-P87 membranes through spin-coating. We also studied the mechanism
through which P87 adsorbs protein-bound toxins by measuring the ζ-potential, and the
effects of pH and salts on P87’ adsorption and desorption.
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7.2 Materials and methods
7.2.1 Materials
Indoxyl sulfate was purchased from Sigma Aldrich, Co. All the other materials are same
as Chapter 6. That is, commercial Ultrason E 6020 PES was obtained from BASF, Co
(U.S.) and used as received. Dimethylacetamide (DMAC) and creatinine were purchased
from Sigma Aldrich, Co. P-87 was purchased from ACS Materials, LLC. 1.5 inch by
1.5 inch glass slides were cut by laser from microscope slides, which is from Ted Pella,
Inc. Ultrapure water was also used. NaCl, KCl and CaCl2 were purchased from Fisher
Scientific, Co.
7.2.2 Measurements
Dynamic light scattering (DLS)
A dynamic light scattering device, Zetasizer Nano ZS (Malvern), was used to analyze
the particle size distribution of zeolite powders. The powders were dissolved in water
at a concentration of 8.6 g L−1 and all samples were tested three times. ζ-potential of
samples was also measured with the same instrument, with a folded capillary zeta cell
(Malvern).
Indoxyl sulfate (IS) adsorption
The indoxyl sulfate adsorption level of PES-zeolite and pristine PES was determined by
an adsorption experiment. Known amounts of dry membranes were put in an indoxyl
sulfate solution (with a concentration of 3.5 mg dL−1) and stirred at 37 ◦C for 0.5, 1
and 3 h. Based on thermal gravimetric analysis (TGA) of PES-zeolite membranes, the
corresponding weight of P87 powders was measured and its indoxyl sulfate adsorption
level was also tested by the same process. All the experiments were repeated three
times. The florescence data of solutions were tested using 1 mm quartz cuvette at room
temperature with excitation of 278 nm and emission of 399 nm. The adsorption level
of each membrane was expressed as µg adsorbed indoxyl sulfate per g of adsorptive
membrane and per g of adsorptive zeolite in membranes. Similarly, the adsorption level
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of indoxyl sulfate by zeolite powder was expressed as µg indoxyl sulfate per g zeolite.
The screening of zeolites through adsorption of IS also carried out as follows: 0.01 g
zeolites were measured and added to tubes. Then, 1 ml indoxyl sulfate solution was
added to the tubes and incubated for 0.5 h. The tubes were centrifuged at 12000 rpm
to precipitate the zeolites. 200 µl supernatants were piped into 1 ml PBS buffer and
mixed well before fluorescence tests.
Effect of pH and salts on IS adsorption by zeolite
To evaluate how pH and salt affect P87’s IS adsorption level, the following experiments
were carried out. The intensities of IS in salts and pH were set as control and measured
through the following procedures. First, a 7.5 mg dL−1 IS solution was made. Then,
500 µl 7.5 mg dL−1 IS solution was mixed with 500 µl water, NaCl , KCl, CaCl2 and
PBS buffer with pH adjusted from 4 to 10. Finally, 200 µl of these mixed solutions were
each added to 1 ml PBS (pH=7.4) and the fluorescence intensity were measured.
Adsorption tests with salt and pH mediums were carried out by measuring 0.01 g
P87 zeolite and placing them into centrifuge tubes with 500 µl 7.5 mg dL−1 IS solutions.
Then, 500 µl water, NaCl, KCl, CaCl2 and PBS buffer (pH 4 to 10) were added into each
centrifuge tube and mixed well. They were centrifuged at 15000 rpm after incubating for
0.5 h. Finally, 200 µl supernatant from each tube was mixed with 1 ml PBS (pH=7.4)
and the fluorescence intensity was measured.
Effect of pH and salts on IS desorption by zeolite
To evaluate whether pH and salts affect P87’s IS desorption, 0.01 g P87 zeolite was
measured and placed into centrifuge tubes with 1 ml of 7.5 mg dL−1 IS solutions. The
mixture was centrifuged at 6000 rpm after 0.5 h incubation to obtain precipitant. The
precipitant was washed with 1.5 ml water to remove non-adsorbed IS. Then, 1 ml water,
NaCl , KCl, CaCl2 and PBS (pH from 4 to 9 ) were added into precipitant and mixed
well. They were further incubated for 0.5 h before being centrifuged at 15000 rpm.
Following this, 200 µl supernatant was mixed with 200 µl PBS before measuring the
fluorescence intensity.
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Figure 7.1: The screening of zeolites.
7.3 Results and discussion
7.3.1 Screening of zeolites
The adsorption of indoxyl sulfate by 10 types of zeolite with 5 different frameworks
was tested and compared. Figure 7.1 shows that only P87 and P371 adsorb indoxyl
sulfate while P87 has a lightly higher adsorption level. As a result, P87 is chosen in the
following studies.
7.3.2 Properties of membranes
Figure 7.2(a) shows the morphology of P87 zeolite powders. They are spherical particles
with grain sizes of 200-400 nm. The images also show that these particles congregated
together. DLS tests in Figure 7.2(b) presented that the average particle size of P87
powder is 1056 nm. The test further confirmed that P87 particles tend to congregate.
Figure 7.2(c, d) presents the cross-section of P87-PES membranes while Figure 7.2(e,f)
shows that of pristine PES membranes. When we compare the morphologies of P87
incorporated membranes with that of pristine PES membranes, three differences are
present: (1) in pristine membranes, the surface is smooth and solid-like, while in P87
composite membranes, the surface is rough and has pores. (2) The channels observed
in the cross section of pristine membranes are clear and with smooth channel surfaces,
while the channels observed in composite membranes have zeolite particles embedded
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Figure 7.2: SEM and DLS of zeolite powders and cross-section of membranes: (a,b) P87
powder, (c,d) PES-P87 membranes, and (e,f) PES membranes.
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Figure 7.3: Adsorption of indoxyl sulfate by P87 powders and membranes at different time:
adsorption level of P87 powder and membranes (a), the fluorescent intensity difference (b).
on the surface. (3) When compared to composite membranes, the pristine membranes
are thinner.
We can tell that the addition of P87 powders in PES membranes resulted in their
morphology and structure changes. As a result, we can expect PES-zeolite membranes
have much higher water flux because of the nanopores on their surface. Water flux
experiments were carried out through the procedure described in Appendix A.6 using
the system illustrated in Figure A.4. The water flux test data in Table A.3 shows greatly
improved water flux for PES-P87 composite membranes when compare to that of pristine
membranes. It is on average 112 g/m2 h mmHg for PES composite membranes and 0.52
g/m2 h mmHg for pristine membranes. The major reason is that the surface pore existed
on P87-PES membranes connect the inner channels and formed a water flow route.
Thermal gravimetric analysis(TGA) tests were also carried out to evaluate the actual
percentage of P87 powders in the membranes. The tests result (shown in Figure A.5)
showed that 46.5 wt% of P87 were incorporated in the membranes, and it is close
to the theoretical data of 50 wt%. The difference between the percentage of zeolite
in precursor solution and in the final membrane was small. This indicates that spin-
coating is a reliable method for fabricating composite membranes with a high percentage
of particles.
7.3.3 Indoxyl sulfate adsorption
It is important to quantify P87 zeolite’s and its membranes’ indoxyl sulfate adsorption
levels. Figure 7.3(a) compares the indoxyl sulfate adsorption level between P87 as pow-
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ders and membranes. Overall, the P87 powders had a higher indoxyl sulfate adsorption
level than its membranes. The reason is that PES matrix tends to block parts of P87
surface, resulting in reduced effective particle adsorption surface. With the adsorption
time increased from 0.5 h to 3 h, the membranes showed similar indoxyl sulfate ad-
sorption levels. However, the zeolite powders had the highest adsorption values in 1
h. A possible explanation is that the adsorption equilibrium process is an adsorption
and desorption process, and the adsorption process takes more than 0.5 h to reach a
balance.
Figure 7.3(b) shows the indoxyl sulfate intensity after being adsorbed by various
materials (pure membranes, PES-zeolite membranes and zeolite powders). It shows
that pristine PES membranes do not adsorb indoxyl sulfate, since the intensity is as
strong as the control group. P87 membranes and P87 powders both partially lowered
25% of the intensity of indoxyl sulfate. It indicates that the membranes and P87 could
partially adsorb indoxyl sulfate in water. However, the adsorption force is weak. We
conjecture that the adsorption happens because of electrostatic attraction between the
particles and indoxyl sulfate.
7.3.4 Mechanism studies of indoxyl sulfate adsorbed by P87 pow-
ders
To study the adsorption mechanism through which P87 zeolites adsorbs indoxyl sulfate,
the ζ-potentials of P87-indoxyl sulfate systems were tested and results were showed
in Table 7.1. The ζ-potential of P87 is 44.0 mV, while that of indoxyl sulfate is -8.0
mV. Since they have opposite charges on the surface of zeolite and indoxyl sulfate, we
expect that indoxyl sulfate will be adsorbed onto zeolite particles through electrostatic
attraction. After we incubated the zeolite particles with indoxyl sulfate, the potential
for zeolite conjugate became 35.6 mV. We then washed the conjugate to eliminate extra
free indoxyl sulfate in the system. After washing, the zeolite potential of the system
became 39.1. The data indicates IS lowered the ζ- potential of the zeolite because IS was
adsorbed onto zeolite. Here we infer that indoxyl sulfate could be adsorbed into zeolites
through molecular sieve or onto the surface of zeolites through electrostatic attraction,
more tests are needed to determine the exact mechanism.
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Table 7.1: ζ-potential studies of P87 powder and indoxyl sulfate.
Sample ζ-potential(mV)(Average)
P87 in water 44.0
IS in water -8.0
P87 + IS conjugate washed 39.1
P87 + IS conjugate unwashed 35.6
Figure 7.4: pH’s effect on indoxyl sulfate adsorption by zeolite.
Figure 7.5: Salt’s effect on indoxyl sulfate adsorption by zeolite.
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Figure 7.6: Illustration of electrostatic attraction and electric blocking of indoxyl sulfate.
In order to determine the adsorption mechanism, experiments were carried out to
measure the effects of pH and salts on the adsorption rate of the zeolite. Figure 7.4
and Figure 7.5 show that in the presence of salt and pH adjusted PBS, P87 zeolite no
longer adsorb indoxyl sulfate anymore. However, the zeolites adsorb around 42 wt% of
indoxyl sulfate in deionized water. In the environment of deionized water, negatively
charged P87 particles attract H+ and form electric double layers (Appendix A.8). They
adsorb indoxyl sulfate through electrostatic attraction. However, the introduction of
pH adjusted PBS buffer and 1M salts solutions bring excessive ions (0.5 mole/L) to the
systems, and the increased ionic strength largely decrease Debye length. The ions also
screen the electrostatic attraction between the zeolite particles and indoxyl sulfate. As
a result, indoxyl sulfate is not adsorbed onto zeolites. Another phenomenon might also
occur with PBS buffer at high pH. Because of the superabundant OH− ions, the Debye
length layer is mainly occupied by OH− ions, thus the zeta potential of the system is
negative. As a result, negatively charged OH− could repulse indoxyl sulfate molecules
away from the surface of P87 zeolites [174]. All these three phenomena are illustrated
in Figure 7.6.
Experiments to determine the effect of pH and salts on zeolite desorption were car-
ried out to further confirm the interaction between zeolite and indoxyl sulfate. Figure 7.7
shows that in the presence of salt and pH adjusted PBS, P87 adsorbed indoxyl sulfate
is eluted into solution. The introduction of PBS with adjusted pH totally interrupted
the attraction between zeolite particles and indoxyl sulfate. The excessive cations and
anions from the salt also replaced the majority part of adsorbed indoxyl sulfate on the
zeolite because electrostatic attraction is a weak force and excessive ions lead to elec-
96
Figure 7.7: pH and salt’s effect on indoxyl sulfate desorption from zeolite.
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tric adsorption screening effects for indoxyl sulfate. In Figure 7.7 (a), we see that the
replacement strength is Na+ > K+. We believe this is related to the size and weight
of the cations. Na+, which has smaller size and lighter weight, moves faster and easier
in the medium, thus exerts more influence on the zeolite-IS conjugates. As a result, in
the NaCl medium, a higher percentage of zeolite-IS conjugate is disrupted. However,
in deionized water, merely a small percentage of indoxyl sulfate was desorbed from ze-
olite particles because of the electric double layer generated by negatively charged P87
attracts indoxyl sulfate.
7.4 Conclusion
Currently, hemodialysis can clear around 70% of urea, but only 30% of protein-bound
toxins. Protein-bound solutes are routinely ignored, as hemodialysis adequacy is typ-
ically benchmarked by urea removal. Increasingly, studies have shown that protein-
bound toxins are related to the progression of chronic kidney disease (CKD), and in the
generation and aggravation of cardiovascular disease. Indoxyl sulfate is usually chosen
as a representative of protein-bound toxins since it plays an important role in causing
reno-cardiovascular syndromes.
In this chapter, we first screened types of zeolite that adsorb indoxyl sulfate. Then we
fabricated polymer-zeolite composite membranes to evaluate whether they can remove
protein-bound toxins through adsorption. We observed that zeolite-PES membranes can
adsorb 550 µg indoxyl sulfate per g membrane in deionized water. We further studied
the mechanism through which P87 zeolite adsorb indoxyl sulfate by measuring the ζ-
potential, and the adsorption effects of pH and salts. We concluded that electrostatic
attraction is likely the mechanism through which P87 adsorbs indoxyl sulfate.
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Chapter 8
Conclusion and future work
The main goal of this thesis was to fabricate hemodialysis membranes that could quickly
eliminate both water-soluble and protein-bond toxins. In Chapter 4, we fabricated a
membrane through electrospinning technology that could adsorb creatinine, a represen-
tative of water-soluble toxins, at high capacity and fast speed. These composite mem-
branes had the potential to reduce the duration of hemodialysis, since they can clear
toxins through diffusion, adsorption and convection. Their pore size, however, was too
large for the purpose of hemodialysis. Therefore, in Chapter 6 and Chapter 7, we pro-
posed spin-coating as a better method to synthesize potential hemodialysis membranes.
We conducted experiments that proved that membranes fabricated through spin-coating
can adsorb both water soluble toxins and protein-bond toxins through adsorption. Fur-
thermore, these membranes have suitable pore-size for hemodialysis. In Chapter 5, we
evaluated the choice of different zeolites in order to maximize the adsorption effect.
The key research findings from each chapter are summarized below.
• Chapter 4 (Toxin adsorption by PAN-zeolite electrospun membranes):
– Novel fibrous membranes using PAN and zeolite particles were fabricated
through electrospinning with the average fiber diameter of 673 nm.
– The creatinine adsorption of 940-zeolite powders increased from 2234 µg/g
in 50 µmol/L creatinine solution to 25423 µg/g in 625 µmol/L creatinine
solution.
– The speed of adsorption was very quick; 0.025 g of 940-zeolite powders could
eliminate 91% of 2 µmol creatinine in 5 min.
• Chapter 5 (Effect of size and shape on zeolite adsorption):
– Size and shape of zeolites had significant effect on their creatinine adsorption
ability when added into membranes.
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– Microparticles presented better adsorption capacity than nanoparticles when
incorporated inside the membranes, although the size does not have any
effect on zeolite powders’ creatinine adsorption.
– The spherical nanoparticle shape proved a better choice than rod nanopar-
ticles when incorporated in the polymer fiber made through electrospinning.
• Chapter 6 (Creatinine adsorption by zeolite-polyethersulfone membranes):
– Polyethersulfone-zeolite membranes were made through a simple spin-coating
process.
– Membranes with 840 could adsorb 4948 µg creatinine per g membranes.
– The incorporation of zeolite into membranes affected the membranes’ pore
channels, thus also affecting the water flux.
– pH and salts effect on zeolites’ creatinine adsorption indicate that the process
is chemical adsorption.
• Chapter 7 (Indoxyl sulfate adsorption by zeolite and zeolite-polyethersulfone mem-
branes):
– Zeolite-PES membranes could adsorb 550 µg indoxyl sulfate per g mem-
branes.
– Electrostatic attraction probably is the mechanism for P87 to adsorb indoxyl
sulfate.
Future work
In this thesis, we found that many types of zeolites (Appendix A.1) are excellent at
adsorbing creatinine. However, only P87 and P371 could adsorb indoxyl sulfate through
electrostatic attraction. A zeolite that can adsorb protein-bound toxin at a high level
remains to be found. Based on the research from Wernert[23], we can see that silicalite
type of zeolite has excellent indoxyl sulfate adsorption capacity. It would be interesting
to test its protein-bound toxin adsorption ability. The adsorption test procedure can
similar to the one used in Chapter 7.
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Based on the results and conclusion from this thesis and Figure 7.1, it is clear that
P87 and P371 can adsorb indoxyl sulfate. They are particles with crystal size 300 and
300 by 700 nm. We conjecture that the mechanism is likely to be electrostatic attraction,
formed due to zeta potential layer. However, it is unclear whether reducing the particle
size can improve the adsorption of indoxyl sulfate. To verify this, mordenite zeolites
with particle size smaller than 50 nm are needed. Then, indoxyl sulfate adsorption tests,
as well as mechanism tests, can be performed as in Chapter 7.
The initial study on the urea acid adsorbing capability of zeolites is shown in in
Appendix A.2 showed that they do not adsorb urea acid. This proved that zeolites have
specific adsorption for uremic toxins. In order to find toxins that could specifically ad-
sorb uric acid, the following directions could be considered. Based on the research from
Wernert[23], we can see that stilbite type of zeolite have excellent uric acid adsorption
capacity. It would be a good start to purchase or synthesis stilbite zeolite and then
























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































[1] U. S. R. D. System., “2015 USRDS annual data report: Epidemiology of kidney
disease in the united states. national institutes of health,,” National Institute of
Diabetes and Digestive and Kidney Diseases, Bethesda, MD,, 2015.
[2] A. Davenport, “Role of dialysis technology in the removal of uremic toxins,”
Hemodialysis International, vol. 15, no. SUPPL. 1, pp. S49–S53, 2011.
[3] G. Eknoyan, G. Beck, A. Cheung, J. Daugirdas, T. Greene, J. Kusek, M. Allon,
J. Bailey, J. Delmez, and T. Depner, “Effect of dialysis dose and membrane flux in
maintenance hemodialysis,” New England Journal of Medicine, vol. 347, no. 25,
pp. 2010–2019, 2002.
[4] A. Davenport and K. Farrington, “Dialysis dose in acute kidney injury and chronic
dialysis,” The Lancet, vol. 375, no. 9716, pp. 705–706, 2010.
[5] A. Ficheux, N. Gayrard, I. Szwarc, D. Andress, S. Soullier, Y. Duny, G. Goubert,
M. Thomas, J. Bismuth-Mondolfo, and J. Daure`s, “The use of SDS-PAGE scan-
ning of spent dialysate to assess uraemic toxin removal by dialysis,” Nephrology
Dialysis Transplantation, pp. 2281–9, 2011.
[6] M. Tijink, J. Janssen, M. Timmer, J. Austen, Y. Aldenhoff, J. Kooman, L. Koole,
J. Damoiseaux, R. Van Oerle, Y. Henskens, and D. Stamatialis, “Development
of novel membranes for blood purification therapies based on copolymers of N-
vinylpyrrolidone and n-butylmethacrylate,” Journal of Materials Chemistry B,
vol. 1, no. 44, pp. 6066–6077, 2013.
[7] A. Azar, Modeling and control of dialysis systems. Springer, 2013.
[8] R. Mehta, J. Kellum, S. Shah, B. Molitoris, C. Ronco, D. Warnock, and A. Levin,
“Acute kidney injury network: report of an initiative to improve outcomes in
acute kidney injury,” Critical Care, vol. 11, no. 2, p. R31, 2007.
159
[9] A. Cheung and J. Leypoldt, “The hemodialysis membranes: a historical per-
spective, current state and future prospect.,” in Seminars in nephrology, vol. 17,
pp. 196–213, 1997.
[10] B. Pereira, A. King, D. Poutsiaka, J. Strom, and C. Dinarello, “Comparison of
first use and reuse of cuprophan membranes on interleukin-1 receptor antagonist
and interleukin-1 beta production by blood mononuclear cells,” American Journal
of Kidney Diseases, vol. 22, no. 2, pp. 288–295, 1993.
[11] D. Falkenhagen, T. Bosch, G. Brown, B. Schmidt, M. Holtz, U. Baurmeister,
H. Gurland, and H. Klinkmann, “A clinical study on different cellulosic dialysis
membranes,” Nephrology Dialysis Transplantation, vol. 2, no. 6, pp. 537–545,
1987.
[12] K. Yamazaki, M. Matsuda, K. Yamamoto, T. Yakushiji, and K. Sakai, “Internal
and surface structure characterization of cellulose triacetate hollow-fiber dialysis
membranes,” Journal of Membrane Science, vol. 368, no. 1-2, pp. 34–40, 2011.
[13] P. Kes, I. Ratkovia-Gusia, and M. Prsa, “Clinical evaluation of Altra-Flux 140
cellulose diacetate hollow-fiber dialyzer,” Acta Medica Croatica, vol. 50, no. 1,
pp. 45–48, 1996.
[14] M. Dewanjee, M. Kapadvanjwala, C. Cavagnaro, G. Panoutsopoulos, C. Sugui-
hara, R. Elson, S. Ezuddin, A. Serafini, G. Zilleruelo, and G. Sfakianakis, “In
vitro and in vivo evaluation of the comparative thrombogenicity of cellulose ac-
etate hemodialyzers with radiolabeled platelets,” ASAIO Journal, vol. 40, no. 1,
pp. 49–55, 1994.
[15] H. Miyazaki, H. Matsuoka, H. Itabe, M. Usui, S. Ueda, S. Okuda, and
T. Imaizumi, “Hemodialysis impairs endothelial function via oxidative stress ef-
fects of vitamin E coated dialyzer,” Circulation, vol. 101, no. 9, pp. 1002–1006,
2000.
[16] T. Oodan, I. Hasegawa, R. Ooishi, T. Nishiyama, H. Amemiya, H. Okuyama,
T. Kobayashi, T. Akizawa, T. Ideura, T. Hiyoshi, and T. Miyazaki, “Modification
160
of porous cellulose dialysis membrane by polyethylene glycol (PEG) grafting,”
Japanese Journal of Artificial Organs, vol. 26, no. 2, pp. 418–422, 1997.
[17] H. Humes, D. Buffington, A. Westover, S. Roy, and W. Fissell, “The bioartificial
kidney: current status and future promise,” Pediatric Nephrology, pp. 1–9, 2013.
[18] S. Roy, A. Dubnisheva, A. Eldridge, A. Fleischman, K. Goldman, H. Humes,
A. Zydney, and W. Fissell, “Silicon nanopore membrane technology for an im-
plantable artificial kidney,” TRANSDUCERS 2009 - 15th International Confer-
ence on Solid-State Sensors, Actuators and Microsystems, pp. 755–760, 2009.
[19] D. Johnson, T. Khire, Y. Lyubarskaya, K. Smith, J. DesOrmeaux, J. Taylor,
T. Gaborski, A. Shestopalov, C. Striemer, and J. McGrath, “Ultrathin silicon
membranes for wearable dialysis,” Advances in Chronic Kidney Disease, vol. 20,
no. 6, pp. 508–515, 2013.
[20] A. Attaluri, Z. Huang, A. Belwalkar, W. Van Geertruyden, D. Gao, and M. W.,
“Evaluation of nano-porous alumina membranes for hemodialysis application,”
ASAIO Journal, vol. 55, no. 3, pp. 217–223, 2009.
[21] M. S. L. Tijink, M. Wester, J. Sun, A. Saris, L. A. M. Bolhuis-Versteeg, S. Saiful,
J. A. Joles, Z. Borneman, M. Wessling, and D. F. Stamatialis, “A novel approach
for blood purification: Mixed-matrix membranes combining diffusion and adsorp-
tion in one step,” Acta Biomaterialia, vol. 8, no. 6, pp. 2279–2287, 2012.
[22] N. Man, J. Zingraff, and P. Jungers, Long-term hemodialysis. Springer Science
Business Media, 2012.
[23] V. Wernert, O. SchA˜f, H. Ghobarkar, and R. Denoyel, “Adsorption properties of
zeolites for artificial kidney applications,”Microporous and Mesoporous Materials,
vol. 83, no. 1-3, pp. 101–113, 2005.
[24] A. Yavuz, C. Tetta, F. F. Ersoy, V. D’Intini, R. Ratanarat, M. De Cal, M. Bonello,
V. Bordoni, G. Salvatori, E. Andrikos, G. Yakupoglu, N. W. Levin, and C. Ronco,
“Uremic toxins: A new focus on an old subject,” Seminars in Dialysis, vol. 18,
no. 3, pp. 203–211, 2005.
161
[25] G. Glorieux, E. Schepers, and R. Vanholder, Cardiorenal syndrome: mechanisms,
risk and treatment, pp. 219–234. Springer, 2010.
[26] E. G. Lowrie and N. L. Lew, “Death risk in hemodialysis patients: the predictive
value of commonly measured variables and an evaluation of death rate differences
between facilities,” American Journal of Kidney Diseases, vol. 15, no. 5, pp. 458–
482, 1990.
[27] S. Liabeuf, T. Dru¨eke, and Z. Massy, “Protein-bound uremic toxins: new insight
from clinical studies,” Toxins, vol. 3, no. 7, pp. 911–919, 2011.
[28] S. Ito and M. Yoshida, “Protein-bound uremic toxins: new culprits of cardiovas-
cular events in chronic kidney disease patients,” Toxins, vol. 6, no. 2, pp. 665–678,
2014.
[29] S. Lekawanvijit, A. R. Kompa, B. H. Wang, D. J. Kelly, and H. Krum, “Cardiore-
nal syndrome: The emerging role of protein-bound uremic toxins,” Circulation
Research, vol. 111, no. 11, pp. 1470–1483, 2012.
[30] S. Fenton, D. Schaubel, M. Desmeules, H. Morrison, Y. Mao, P. Copleston, J. Jef-
fery, and C. Kjellstrand, “Hemodialysis versus peritoneal dialysis: a comparison
of adjusted mortality rates,” American Journal of Kidney Diseases, vol. 30, no. 3,
pp. 334–342, 1997.
[31] A. Bright and B. Makin, “Polar liquids: A survey of purification, conduction
mechanisms, and interfacial effects,” Journal of Materials Science, vol. 2, no. 2,
pp. 184–193, 1967.
[32] J. Filippini and C. Meyer, “Water treeing using the water needle method: the in-
fluence of the magnitude of the electric field at the needle tip,” IEEE Transactions
on Electrical Insulation, vol. 23, no. 2, pp. 275–278, 1988.
[33] F. Pontiga and A. Castellanos, “The effect of field-enhanced injection and dis-
sociation on the conduction of highly-insulating liquids,” IEEE Transactions on
Dielectrics and Electrical Insulation, vol. 3, no. 6, pp. 792–799, 1996.
162
[34] A. Yarin, S. Koombhongse, and D. Reneker, “Taylor cone and jetting from liquid
droplets in electrospinning of nanofibers,” Journal of Applied Physics, vol. 90,
no. 9, pp. 4836–4846, 2001.
[35] J. Feng, “The stretching of an electrified non-newtonian jet: A model for electro-
spinning,” Physics of Fluids, vol. 14, no. 11, pp. 3912–3926, 2002.
[36] M. Hohman, M. Shin, G. Rutledge, and M. Brenner, “Electrospinning and elec-
trically forced jets. i. stability theory,” Physics of Fluids, vol. 13, no. 8, pp. 2201–
2220, 2001.
[37] G. Rutledge and S. Fridrikh, “Formation of fibers by electrospinning,” Advanced
Drug Delivery Reviews, vol. 59, no. 14, pp. 1384–1391, 2007.
[38] S. Theron, E. Zussman, and A. Yarin, “Experimental investigation of the gov-
erning parameters in the electrospinning of polymer solutions,” Polymer, vol. 45,
no. 6, pp. 2017–2030, 2004.
[39] W. Teo and S. Ramakrishna, “A review on electrospinning design and nanofibre
assemblies,” Nanotechnology, vol. 17, no. 14, pp. R89–R106, 2006.
[40] C. Baerlocher, L. McCusker, and D. Olson, Atlas of zeolite framework types. El-
sevier, 2007.
[41] H. Sirringhaus, N. Tessler, and R. H. Friend, “Integrated optoelectronic devices
based on conjugated polymers,” Science, vol. 280, no. 5370, pp. 1741–1744, 1998.
[42] H. Sirringhaus, P. J. Brown, R. H. Friend, M. M. Nielsen, K. Bechgaard,
B. M. W. Langeveld-Voss, A. J. H. Spiering, R. A. J. Janssen, and E. W. Meijer,
“Microstructure-mobility correlation in self-organised, conjugated polymer field-
effect transistors,” Synthetic Metals, vol. 111, pp. 129–132, 2000.
[43] A. Salleo, M. L. Chabinyc, M. S. Yang, and R. A. Street, “Polymer thin-film
transistors with chemically modified dielectric interfaces,” Applied Physics Letters,
vol. 81, no. 23, pp. 4383–4385, 2002.
163
[44] K. Eaton, “A novel colorimetric oxygen sensor: Dye redox chemistry in a thin
polymer film,” Sensors and Actuators, B: Chemical, vol. 85, no. 1-2, pp. 42–51,
2002.
[45] P. Douglas and K. Eaton, “Response characteristics of thin film oxygen sensors,
Pt and Pd octaethylporphyrins in polymer films,” Sensors and Actuators, B:
Chemical, vol. 82, no. 2-3, pp. 200–208, 2002.
[46] D. Chang, D. Yoon, M. Ro, I. Hwang, I. Park, and D. Shin, “Synthesis and
characteristics of protective coating on thin cover layer for high density-digital
versatile disc,” Japanese Journal of Applied Physics, vol. 42, no. 2 B, pp. 754–
758, 2003.
[47] S. Walheim, E. Scha¨ffer, J. Mlynek, and U. Steiner, “Nanophase-separated poly-
mer films as high-performance antireflection coatings,” Science, vol. 283, no. 5401,
pp. 520–522, 1999.
[48] T. Xu, H. C. Kim, J. DeRouchey, C. Seney, C. Levesque, P. Martin, C. M. Stafford,
and T. P. Russell, “The influence of molecular weight on nanoporous polymer
films,” Polymer, vol. 42, no. 21, pp. 9091–9095, 2001.
[49] K. Norrman, A. Ghanbari-Siahkali, and N. B. Larsen, “Studies of spin-coated
polymer films,” Annual Reports on the Progress of Chemistry - Section C, vol. 101,
pp. 174–201, 2005.
[50] L. McCusker, F. Liebau, and G. Engelhardt, “Nomenclature of structural and
compositional characteristics of ordered microporous and mesoporous materials
with inorganic hosts,” Pure and Applied Chemistry, vol. 73, no. 2, pp. 381–394,
2001.
[51] M. Estermann, L. McCusker, C. Baerlocher, A. Merrouche, and H. Kessler, “A
synthetic gallophosphate molecular sieve with a 20-tetrahedral-atom pore open-
ing,” Nature, vol. 352, no. 6333, pp. 320–323, 1991.
[52] T. Wessels, C. Baerlocher, L. McCusker, and E. Creyghton, “An ordered form
of the extra-large-pore zeolite UTD-1: Synthesis and structure analysis from
164
powder diffraction data,” Journal of the American Chemical Society, vol. 121,
no. 26, pp. 6242–6247, 1999.
[53] W. K. Cheah, K. Ishikawa, R. Othman, and F. Y. Yeoh, “Nanoporous biomaterials
for uremic toxin adsorption in artificial kidney systems: A review,” Journal of
Biomedical Materials Research - Part B Applied Biomaterials, 2016.
[54] J. F. Winchester, N. B. Harbord, E. Charen, and M. Ghannoum, Use of dialysis
and hemoperfusion in the treatment of poisoning. 2014.
[55] E. Muirhead and A. Reid, “A resin artificial kidney,” The Journal of Laboratory
and Clinical Medicine, vol. 33, no. 7, pp. 841–844, 1948.
[56] G. Hampel, P. Crome, B. Widdop, and R. Goulding, “Experience with fixed-bed
charcoal haemoperfusion in the treatment of severe drug intoxication,” Archives
of Toxicology, vol. 45, no. 2, pp. 133–141, 1980.
[57] M. Gelfand, J. Winchester, J. Knepshield, K. Hanson, S. Cohan, B. Strauch,
K. Geoly, A. Kennedy, and G. Schreiner, “Treatment of severe drug overdosage
with charcoal hemoperfusion,” ASAIO Journal, vol. 23, no. 1, pp. 599–604, 1977.
[58] G. Verpooten and M. De Broe, “Combined hemoperfusion-hemodialysis in severe
poisoning: kinetics of drug extraction,” Resuscitation, vol. 11, no. 3-4, pp. 275–
289, 1984.
[59] W. Watson, T. Litovitz, G. Rodgers, W. Klein-Schwartz, N. Reid, J. Youniss,
A. Flanagan, and K. Wruk, “2004 annual report of the American association of
poison control centers toxic exposure surveillance system,” The American Journal
of Emergency Medicine, vol. 23, no. 5, pp. 589–666, 2005.
[60] N. B. Harbord, Z. Z. Brener, D. A. Feinfeld, and J. F. Winchester, Dialysis and
hemoperfusion in the treatment of poisoning and drug overdose, pp. 1073–1080.
2008.
[61] M. Ghannoum, J. Bouchard, T. D. Nolin, G. Ouellet, and D. M. Roberts, “Hemop-
erfusion for the treatment of poisoning: Technology, determinants of poison clear-
ance, and application in clinical practice,” Seminars in Dialysis, vol. 27, no. 4,
pp. 350–361, 2014.
165
[62] V. Gura, A. Macy, M. Beizai, C. Ezon, and T. Golper, “Technical breakthroughs
in the wearable artificial kidney (WAK),” Clinical Journal of the American Society
of Nephrology, vol. 4, no. 9, pp. 1441–1448, 2009.
[63] A. Davenport, V. Gura, C. Ronco, M. Beizai, C. Ezon, and E. Rambod, “A
wearable haemodialysis device for patients with end-stage renal failure: a pilot
study,” The Lancet, vol. 370, no. 9604, pp. 2005–2010, 2007.
[64] C. Ronco, M. Haapio, A. A. House, N. Anavekar, and R. Bellomo, “Cardiore-
nal syndrome,” Journal of the American College of Cardiology, vol. 52, no. 19,
pp. 1527–1539, 2008.
[65] C. Ronco, A. Davenport, and V. Gura, “Toward the wearable artificial kidney,”
Hemodialysis International, vol. 12, no. s1, pp. S40–S47, 2008.
[66] H. Polaschegg, Wearable dialysis: what is missing?, vol. 171, pp. 226–230. Karger
Publishers, 2011.
[67] F. Yoshida, “Apparatus for treatment of artificial kidney dialyzing fluid,” Oct. 3
1978. US Patent 4,118,314.
[68] W. Henne, “Artificial kidney,” July 15 1980. US Patent 4,212,738.
[69] V. Davankov, “Artificial kidney,” Aug. 13 1996. US Patent 5,545,131.
[70] A. Granger and A. Sausse, “Artificial kidney and a method of ultrafiltering a
liquid,” Feb. 17 1976. US Patent 3,939,069.
[71] V. Gura and E. Rambod, “Wearable ultrafiltration device,” Jan. 12 2010. US
Patent 7,645,253.
[72] G. Eknoyan, “Artificial kidneys: progress and promise,” The Lancet, vol. 370,
no. 9604, pp. 1977–1978, 2007.
[73] M. Roberts, “The regenerative dialysis (REDY) sorbent system,” Nephrology,
vol. 4, no. 4, pp. 275–278, 1998.
[74] H. Yatzidis, “Charcoal for the treatment of endogenous and exogenous intoxica-
tions. its use as an effective artificial kidney,” in Proc Eur Dialysis Transplant
Assoc, vol. 1, p. 83.
166
[75] E. Chirito, B. Reiter, C. Lister, and T. Chang, “Artificial liver: the effect of
ACAC microencapsulated charcoal hemoperfusion on fulminant hepatic failure,”
Artificial Organs, vol. 1, no. 1, pp. 76–83, 1977.
[76] A. Shnyra, A. Bocharov, N. Bochkova, and V. Spirov, “Bioartificial liver using
hepatocytes on biosilon microcamers: treatment of chemically induced acute hep-
atic failure in rats,” Artificial Organs, vol. 15, no. 3, pp. 189–197, 1991.
[77] S. Borkan, “Extracorporeal therapies for acute intoxications,” Critical Care Clin-
ics, vol. 18, no. 2, pp. 393–420, 2002.
[78] J. Wang, X. Yang, D. Wu, R. Fu, M. Dresselhaus, and G. Dresselhaus, “The
porous structures of activated carbon aerogels and their effects on electrochemical
performance,” Journal of Power Sources, vol. 185, no. 1, pp. 589–594, 2008.
[79] I. Tan, A. Ahmad, and B. Hameed, “Adsorption of basic dye on high-surface-area
activated carbon prepared from coconut husk: Equilibrium, kinetic and thermo-
dynamic studies,” Journal of Hazardous Materials, vol. 154, no. 1, pp. 337–346,
2008.
[80] K. Singh, D. Mohan, S. Sinha, G. Tondon, and D. Gosh, “Color removal from
wastewater using low-cost activated carbon derived from agricultural waste mate-
rial,” Industrial & Engineering Chemistry Research, vol. 42, no. 9, pp. 1965–1976,
2003.
[81] B. Reed and S. Nonavinakere, “Metal adsorption by activated carbon: effect of
complexing ligands, competing adsorbates, ionic strength, and background elec-
trolyte,” Separation Science and Technology, vol. 27, no. 14, pp. 1985–2000, 1992.
[82] R. C. Bansal, J. Donnet, and F. Stoeckli, Active carbon. M. Dekker, 1988.
[83] S. Murugesan, T. Park, H. Yang, S. Mousa, and R. Linhardt, “Blood compat-
ible carbon nanotubes-nano-based neoproteoglycans,” Langmuir, vol. 22, no. 8,
pp. 3461–3463, 2006.
[84] J. Buturovic´, R. Ponikvar, M. Kandus, A.and Boh, J. Klinkmann, and
P. Ivanovich, “Filling hemodialysis catheters in the interdialytic period: hep-
167
arin versus citrate versus polygeline: a prospective randomized study,” Artificial
Organs, vol. 22, no. 11, pp. 945–947, 1998.
[85] W. Yantasee, G. Fryxell, G. A. Porter, K. Pattamakomsan, V. Sukwarotwat,
W. Chouyyok, J. Xu, and K. Raymond, “Novel sorbents for removal of gadolinium-
based contrast agents in sorbent dialysis and hemoperfusion: preventive ap-
proaches to nephrogenic systemic fibrosis,” Nanomedicine: Nanotechnology, Biol-
ogy and Medicine, vol. 6, no. 1, pp. 1–8, 2010.
[86] T. Chang, A. Gonda, J. Dirks, and N. Malave, “Clinical evaluation of chronic,
intermittent, and short term hemoperfusions in patients with chronic renal failure
using semipermeable microcapsules (artificial cells) formed from membrane-coated
activated charcoal,” ASAIO Journal, vol. 17, no. 1, pp. 246–252, 1971.
[87] S. Lee, C.and Hsu, “Preparation of spherical encapsulation of activated carbons
and their adsorption capacity of typical uremic toxins,” Journal of Biomedical
Materials Research, vol. 24, no. 2, pp. 243–258, 1990.
[88] N. Bastu´s, E. Casals, and V. Socorro, V.C.and Puntes, “Reactivity of engineered
inorganic nanoparticles and carbon nanostructures in biological media,” Nanotox-
icology, vol. 2, no. 3, pp. 99–112, 2008.
[89] F. Cataldo and T. Da Ros, Medicinal chemistry and pharmacological potential of
fullerenes and carbon nanotubes, vol. 1. Springer Science Business Media, 2008.
[90] S. Mikhalovsky, “Emerging technologies in extracorporeal treatment: focus on
adsorption,” Perfusion, vol. 18, no. 1 suppl, pp. 47–54, 2003.
[91] J. Andrade, K. Kunitomo, V. Wagenen, B. Kastigir, D. Gough, and W. Kolff,
“Coated adsorbents for direct blood perfusion: HEMA-activated carbon,” ASAIO
Journal, vol. 17, no. 1, pp. 222–228, 1971.
[92] Y. Zhang, C. Xu, Y. He, X. Wang, F. Xing, H. Qiu, Y. Liu, D. Ma, T. Lin, and
J. Gao, “Zeolite/polymer composite hollow microspheres containing antibiotics
and the in vitro drug release,” Journal of Biomaterials Science, Polymer Edition,
vol. 22, no. 4-6, pp. 809–822, 2011.
168
[93] R. S. Bedi, L. P. Zanello, and Y. Yan, “Osteoconductive and osteoinductive prop-
erties of zeolite MFI coatings on titanium alloys,” Advanced Functional Materials,
vol. 19, no. 24, pp. 3856–3861, 2009.
[94] E. Streicher and H. Schneider, “Polysulphone membrane mimicking human
glomerular basement membrane,” The Lancet, vol. 322, no. 8359, p. 1136, 1983.
[95] T. Takeyama and Y. Sakai, Polymethylmethacrylate: one biomaterial for a series
of membrane, vol. 125, pp. 9–24. Karger Publishers, 1999.
[96] A. Bazargan, M. Keyanpour-rad, F. Hesari, and M. Ganji, “A study on the micro-
filtration behavior of self-supporting electrospun nanofibrous membrane in water
using an optical particle counter,” Desalination, vol. 265, no. 1-3, pp. 148–152,
2011.
[97] D. Bastani, N. Esmaeili, and M. Asadollahi, “Polymeric mixed matrix membranes
containing zeolites as a filler for gas separation applications: A review,” Journal
of Industrial and Engineering Chemistry, vol. 19, no. 2, pp. 375–393, 2013.
[98] C. Nie, L. Ma, Y. Xia, J. He, C.and Deng, L. Wang, C. Cheng, S. Sun, and
C. Zhao, “Novel heparin-mimicking polymer brush grafted carbon nanotube/PES
composite membranes for safe and efficient blood purification,” Journal of Mem-
brane Science, vol. 475, pp. 455–468, 2015.
[99] D. Krieter, M. Grude, H. Lemke, E. Fink, B. A. Bo¨nner, G.and Scho¨lkens,
E. Schulz, and G. Mu¨ller, “Anaphylactoid reactions during hemodialysis in sheep
are ACE inhibitor dose-dependent and mediated by bradykinin,” Kidney Inter-
national, vol. 53, no. 4, pp. 1026–1035, 1998.
[100] L. Verresen, M. Waer, Y. Vanrenterghem, and P. Michielsen, “Angiotensin-
converting-enzyme inhibitors and anaphylactoid reactions to high-flux membrane
dialysis,” The Lancet, vol. 336, no. 8727, pp. 1360–1362, 1990.
[101] C. Randoux, P. Gillery, and N. Georges, “Filtration of native and glycatedbeta 2-
microglobulin by charged and neutral dialysis membrane,” Kidney International,
vol. 60, no. 4, pp. 157–177.
169
[102] J. Chanard, S. Lavaud, H. Maheut, I. Kazes, F. Vitry, and P. Rieu, “The clin-
ical evaluation of low-dose heparin in haemodialysis: a prospective study using
the heparin-coated AN69 ST membrane,” Nephrology Dialysis Transplantation,
vol. 23, no. 6, pp. 2003–2009, 2008.
[103] A. Kandus, M. Malovrh, and A. Bren, “Influence of blood flow on ddsorption of
β2-microglobulin onto AN69 membrane,” Artificial organs, vol. 21, no. 8, pp. 903–
906, 1997.
[104] N. A. Hoenich, S. Stamp, and S. J. Roberts, “A microdomain-structured synthetic
high-flux hollow-fiber membrane for renal replacement therapy,” ASAIO Journal,
vol. 46, no. 1, pp. 70–75, 2000.
[105] K. Namekawa, A. Kaneko, K. Sakai, S. Kunikata, and M. Matsuda, “Longer stor-
age of dialyzers increases elution of poly(N-vinyl-2- pyrrolidone) from polysulfone-
group dialysis membranes,” Journal of Artificial Organs, vol. 14, no. 1, pp. 52–57,
2011.
[106] R. Vanholder, A. Argile´s, U. Baurmeister, P. Brunet, W. Clark, G. Cohen, P. P.
De Deyn, R. Deppisch, B. Descamps-Latscha, T. Henle, A. Jo¨rres, Z. A. Massy,
M. Rodriguez, B. Stegmayr, P. Stenvinkel, and M. L. Wratten, “Uremic toxicity:
Present state of the art,” International Journal of Artificial Organs, vol. 24, no. 10,
pp. 695–725, 2001.
[107] D. Berge´-Lefranc, H. Pizzala, J. L. Paillaud, O. Scha¨f, C. Vagner, P. Boulet,
B. Kuchta, and R. Denoyel, “Adsorption of small uremic toxin molecules on MFI
type zeolites from aqueous solution,” Adsorption, vol. 14, no. 2-3, pp. 377–387,
2008.
[108] D. Berge´-Lefranc, M. Eyraud, and O. Scha¨f, “Electrochemical determination of p-
cresol concentration using zeolite-modified electrodes,” Comptes Rendus Chimie,
vol. 11, no. 9, pp. 1063–1073, 2008.
[109] D. Berge´-Lefranc, C. Vagner, O. Scha¨f, P. Boulet, H. Pizzala, J. Paillaud, and
R. Denoyel, “Adsorption of small uremic toxin molecules onto zeolites: a first
170
step towards an alternative kidney,” Studies in Surface Science and Catalysis,
vol. 170, pp. 1015–1020, 2007.
[110] D. Berge´-Lefranc, H. Pizzala, R. Denoyel, V. Hornebecq, J. L. Berge´-Lefranc,
R. Guieu, P. Brunet, H. Ghobarkar, and O. Scha¨f, “Mechanism of creatinine
adsorption from physiological solutions onto mordenite,” Microporous and Meso-
porous Materials, vol. 119, no. 1-3, pp. 186–192, 2009.
[111] T. Pechar, S. Kim, B. Vaughan, E. Marand, M. Tsapatsis, H. Jeong, and C. Cor-
nelius, “Fabrication and characterization of polyimide-zeolite l mixed matrix mem-
branes for gas separations,” Journal of Membrane Science, vol. 277, no. 1, pp. 195–
202, 2006.
[112] N. Moreno, X. Querol, C. Ayora, C. F. Pereira, and M. Janssen-Jurkovicova´,
“Utilization of zeolites synthesized from coal fly ash for the purification of acid
mine waters,” Environmental Science and Technology, vol. 35, no. 17, pp. 3526–
3534, 2001.
[113] E. A´lvarez Ayuso, A. Garc´ıa-Sa´nchez, and X. Querol, “Purification of metal elec-
troplating waste waters using zeolites,” Water Research, vol. 37, no. 20, pp. 4855–
4862, 2003.
[114] C. I. Chaidou, G. Pantoleontos, D. E. Koutsonikolas, S. P. Kaldis, and G. P.
Sakellaropoulos, “Gas separation properties of polyimide-zeolite mixed matrix
membranes,” Separation Science and Technology (Philadelphia), vol. 47, no. 7,
pp. 950–962, 2012.
[115] Z. Cheng, Z. Chao, and H. Wan, “Progress in the research of zeolite membrane
on gas separation,” Progress in Chemistry, vol. 16, no. 1, pp. 61–67, 2004.
[116] H. Ma, B. Hsiao, and B. Chu, “Functionalized electrospun nanofibrous microfil-
tration membranes for removal of bacteria and viruses,” Journal of Membrane
Science, vol. 452, pp. 446–452, 2014.
[117] X. Chen, Y. Su, F. Shen, and Y. Wan, “Antifouling ultrafiltration membranes
made from PAN-b-PEG copolymers: Effect of copolymer composition and PEG
chain length,” Journal of Membrane Science, vol. 384, no. 1, pp. 44–51, 2011.
171
[118] Z. G. Wang, L. S. Wan, and Z. K. Xu, “Surface engineerings of polyacrylonitrile-
based asymmetric membranes towards biomedical applications: An overview,”
Journal of Membrane Science, vol. 304, no. 1-2, pp. 8–23, 2007.
[119] M. Pascual and J. Schifferli, “Adsorption of complement factor d by polyacryloni-
trile dialysis membranes,” Kidney International, vol. 43, pp. 903–903, 1993.
[120] W. Lin, T. Liu, and M. Yang, “Hemocompatibility of polyacrylonitrile dialy-
sis membrane immobilized with chitosan and heparin conjugate,” Biomaterials,
vol. 25, no. 10, pp. 1947–1957, 2004.
[121] L. Smeby, T. Widerøe, and S. Balstad, T.and Jørstad, “Biocompatibility aspects
of cellophane, cellulose acetate, polyacrylonitrile, polysulfone and polycarbonate
hemodialyzers,” Blood Purification, vol. 4, no. 1-3, pp. 93–101, 1986.
[122] M. Obaid, O. A. Fadali, B.-H. Lim, H. Fouad, and N. A. M. Barakat, “Super-
hydrophilic and highly stable in oils polyamide-polysulfone composite membrane
by electrospinning,” Materials Letters, vol. 138, no. 0, pp. 196–199, 2015.
[123] Z. Ma, M. Kotaki, and S. Ramakrishna, “Electrospun cellulose nanofiber as affin-
ity membrane,” Journal of Membrane Science, vol. 265, no. 1-2, pp. 115–123,
2005.
[124] H. S. Bae, A. Haider, K. M. K. Selim, D. Y. Kang, E. J. Kim, and I. K. Kang,
“Fabrication of highly porous PMMA electrospun fibers and their application in
the removal of phenol and iodine,” Journal of Polymer Research, vol. 20, no. 7,
2013.
[125] R. Nirmala, R. Navamathavan, S. J. Park, and H. Y. Kim, “Recent progress on
the fabrication of ultrafine polyamide-6 based nanofibers via electro- spinning: A
topical review,” Nano-Micro Letters, vol. 6, no. 2, pp. 89–107, 2014.
[126] A. Krupa, A. Jaworek, S. Sundarrajan, D. Pliszka, and S. Ramakrishna, “Me-
chanical properties an of electrospun polymer fibre-metal oxide nanocomposite
mat,” Fibres and Textiles in Eastern Europe, vol. 91, no. 2, pp. 25–27, 2012.
172
[127] G. Zhang, H. Meng, and S. Ji, “Hydrolysis differences of polyacrylonitrile support
membrane and its influences on polyacrylonitrile-based membrane performance,”
Desalination, vol. 242, no. 1-3, pp. 313–324, 2009.
[128] X. Cao, M. Huang, B. Ding, J. Yu, and G. Sun, “Robust polyacrylonitrile nanofi-
brous membrane reinforced with jute cellulose nanowhiskers for water purifica-
tion,” Desalination, vol. 316, pp. 120–126, 2013.
[129] K. Yoon, B. S. Hsiao, and B. Chu, “High flux ultrafiltration nanofibrous mem-
branes based on polyacrylonitrile electrospun scaffolds and crosslinked polyvinyl
alcohol coating,” Journal of Membrane Science, vol. 338, no. 1-2, pp. 145–152,
2009.
[130] J. Ahn, W. Chung, I. Pinnau, and M. Guiver, “Polysulfone/silica nanoparti-
cle mixed-matrix membranes for gas separation,” Journal of Membrane Science,
vol. 314, no. 1-2, pp. 123–133, 2008.
[131] L. Vane, V. Namboodiri, and T. Bowen, “Hydrophobic zeolite-silicone rubber
mixed matrix membranes for ethanol-water separation: Effect of zeolite and sili-
cone component selection on pervaporation performance,” Journal of Membrane
Science, vol. 308, no. 1-2, pp. 230–241, 2008.
[132] D. Zadaka-Amir, A. Nasser, S. Nir, and Y. Mishael, “Removal of methyl tertiary-
butyl ether (MTBE) from water by polymer–zeolite composites,”Microporous and
Mesoporous Materials, vol. 151, pp. 216–222, 2012.
[133] K. Namekawa, M. Tokoro Schreiber, T. Aoyagi, and M. Ebara, “Fabrication of
zeolite-polymer composite nanofibers for removal of uremic toxins from kidney
failure patients,” Biomaterials Science, vol. 2, no. 5, pp. 674–679, 2014.
[134] D. Berge-Lefranc, C. Vagner, R. Calaf, H. Pizzala, R. Denoyel, P. Brunet, H. Gho-
barkar, and O. SchA˜f, “In vitro elimination of protein bound uremic toxin p-cresol
by MFI-type zeolites,” Microporous and Mesoporous Materials, vol. 153, pp. 288–
293, 2012.
[135] M. S. Tijink, M. Wester, G. Glorieux, K. Gerritsen, J. Sun, P. Swart, Z. Borneman,
M. Wessling, R. Vanholder, and J. Joles, “Mixed matrix hollow fiber membranes
173
for removal of protein-bound toxins from human plasma,” Biomaterials, vol. 34,
no. 32, pp. 7819–7828, 2013.
[136] L. Lu, C. Samarasekera, and J. T. Yeow, “Creatinine adsorption capacity of elec-
trospun polyacrylonitrile (PAN)-zeolite nanofiber membranes for potential artifi-
cial kidney applications,” Journal of Applied Polymer Science, 2015.
[137] S¸. B. Tantekin-Ersolmaz, C¸. Atalay-Oral, M. Tatlıer, A. Erdem-S¸enatalar,
B. Schoeman, and J. Sterte, “Effect of zeolite particle size on the performance
of polymer–zeolite mixed matrix membranes,” Journal of Membrane Science,
vol. 175, no. 2, pp. 285–288, 2000.
[138] J. C. Chen, J. A. Wu, K. H. Lin, P. J. Lin, and J. H. Chen, “Preparation of micro-
filtration membranes with controlled pore sizes by interfacial polymerization on
electrospun nanofibrous membranes,” Polymer Engineering and Science, vol. 54,
no. 2, pp. 430–437, 2014.
[139] V. Wernert, O. SchA˜f, V. Faure, P. Brunet, L. Dou, Y. Berland, P. Boulet,
B. Kuchta, and R. Denoyel, “Adsorption of the uremic toxin p-cresol onto
hemodialysis membranes and microporous adsorbent zeolite silicalite,” Journal
of Biotechnology, vol. 123, no. 2, pp. 164–173, 2006.
[140] K. Sakai, “Determination of pore size and pore size distribution. 2. dialysis mem-
branes,” Journal of Membrane Science, vol. 96, no. 1-2, pp. 91–130, 1994.
[141] H. J. Gurland, J. C. Fernandez, W. Samtleben, and L. A. Castro, “Sorbent mem-
branes used in a conventional dialyzer format. in vitro and clinical evaluation,”
Artificial Organs, vol. 2, no. 4, pp. 372–374, 1978.
[142] P. S. Malchesky, W. Piatkiewicz, W. G. Varnes, L. Ondercin, and Y. Nose´, “Sor-
bent membranes: Device designs, evaluations and potential applications,” Artifi-
cial Organs, vol. 2, no. 4, pp. 367–371, 1978.
[143] T. Akizawa, “Adsorbent: A determinant for the future development of therapeutic
apheresis,” Therapeutic Apheresis, vol. 2, no. 1, pp. 1–2, 1998.
174
[144] G. La Greca, A. Brendolan, P. M. Ghezzi, R. De Smet, C. Tetta, R. Gervasio,
and C. Ronco, “The concept of sorbent in hemodialysis,” International Journal
of Artificial Organs, vol. 21, no. 6, pp. 303–308, 1998.
[145] S. K. Hansen, “Advances in sorbent dialysis,” Dialysis and Transplantation,
vol. 34, no. 9, pp. 652+648–650, 2005.
[146] J. F. Winchester and C. Ronco, “Sorbent augmented hemodialysis systems: Are
we there yet?,” Journal of the American Society of Nephrology, vol. 21, no. 2,
pp. 209–211, 2010.
[147] T. W. Meyer, J. W. T. Peattie, J. D. Miller, D. C. Dinh, N. S. Recht, J. L.
Walther, and T. H. Hostetter, “Increasing the clearance of protein-bound solutes
by addition of a sorbent to the dialysate,” Journal of the American Society of
Nephrology, vol. 18, no. 3, pp. 868–874, 2007.
[148] J. W. M. Agar, “Review: Understanding sorbent dialysis systems,” Nephrology,
vol. 15, no. 4, pp. 406–411, 2010.
[149] S. Ash, “Sorbents in treatment of uremia: A short history and a great future,”
Seminars in Dialysis, vol. 22, no. 6, pp. 615–622, 2009.
[150] E. Klein, F. F. Holland, and K. Eberle, “Sorbent-filled hollow fibers for hemopurifi-
cation,” Transactions of the American Society for Artificial Organs, vol. VOL.24,
pp. 127–130, 1978.
[151] W. Samtleben, C. Dengler, B. Reinhardt, A. Nothdurft, and H. D. Lemke, “Com-
parison of the new polyethersulfone high-flux membrane DIAPESR© HF800 with
conventional high-flux membranes during on-line haemodiafiltration,” Nephrology
Dialysis Transplantation, vol. 18, no. 11, pp. 2382–2386, 2003.
[152] L. Lu, C. Chen, C. Samarasekera, and J. Yeow, “Influence of zeolite shape and
particle size on their capacity to adsorb uremic toxin as powders and as fillers in
membranes,” Journal of Biomedical Materials Research Part B: Applied Bioma-
terials, pp. n/a–n/a, 2016.
175
[153] B. H. Su, P. Fu, Q. Li, Y. Tao, Z. Li, H. S. Zao, and C. S. Zhao, “Evaluation of
polyethersulfone highflux hemodialysis membrane in vitro and in vivo,” Journal
of Materials Science: Materials in Medicine, vol. 19, no. 2, pp. 745–751, 2008.
[154] R. E. Reddick and G. L. Kenyon, “Syntheses and NMR studies of specifically
labeled [2-15N]phosphocreatine, [2-15N]creatinine, and related 15N-labeled com-
pounds,” Journal of the American Chemical Society, vol. 109, no. 14, pp. 4380–
4387, 1987.
[155] V. Remond, D. Reta, and H. Chen, “Uremic toxicity: the middle molecule hy-
pothesis resisted,” in Seminars in Nephrol, vol. 14, pp. 205–218, 1994.
[156] R. Vanholder and R. DE SMET, “Pathophysiologic effects of uremic retention
solutes,” Journal of the American Society of Nephrology, vol. 10, no. 8, pp. 1815–
1823, 1999.
[157] R. Vanholder, U. Baurmeister, P. Brunet, G. Cohen, G. Glorieux, and
J. Jankowski, “A bench to bedside view of uremic toxins,” Journal of the Ameri-
can Society of Nephrology, vol. 19, no. 5, pp. 863–870, 2008.
[158] R. Vanholder, S. Van Laecke, and G. Glorieux, “What is new in uremic toxicity?,”
Pediatric Nephrology, vol. 23, no. 8, pp. 1211–1221, 2008.
[159] Y. Itoh, A. Ezawa, K. Kikuchi, Y. Tsuruta, and T. Niwa, “Protein-bound ure-
mic toxins in hemodialysis patients measured by liquid chromatography/tandem
mass spectrometry and their effects on endothelial ros production,” Analytical
and Bioanalytical Chemistry, vol. 403, no. 7, pp. 1841–1850, 2012.
[160] A. W. Martinez, N. S. Recht, T. H. Hostetter, and T. W. Meyer, “Removal of
P-cresol sulfate by hemodialysis,” Journal of the American Society of Nephrology,
vol. 16, no. 11, pp. 3430–3436, 2005.
[161] C. Lin, C. Wu, C. Pan, Y. Chen, F. Sun, and H. Chen, “Serum protein-bound
uraemic toxins and clinical outcomes in haemodialysis patients,” Nephrology Dial-
ysis Transplantation, vol. 25, no. 11, pp. 3693–3700, 2010.
176
[162] T. Niwa and M. Ise, “Indoxyl sulfate, a circulating uremic toxin, stimulates the
progression of glomerular sclerosis,” Journal of Laboratory and Clinical Medicine,
vol. 124, no. 1, pp. 96–104, 1994.
[163] B. Meijers, K. Claes, B. Bammens, H. de Loor, L. Viaene, K. Verbeke, D. Kuypers,
Y. Vanrenterghem, and P. Evenepoel, “p-Cresol and cardiovascular risk in mild-to-
moderate kidney disease,” Clinical Journal of the American Society of Nephrology,
vol. 5, no. 7, pp. 1182–1189, 2010.
[164] B. Meijers, B. Bammens, B.and De Moor, K. Verbeke, Y. Vanrenterghem, and
P. Evenepoel, “Free p-cresol is associated with cardiovascular disease in hemodial-
ysis patients,” Kidney International, vol. 73, no. 10, pp. 1174–1180, 2008.
[165] L. Dou, E. Bertrand, C. Cerini, V. Faure, J. Sampol, R. Vanholder, Y. Berland,
and P. Brunet, “The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial
proliferation and wound repair,” Kidney international, vol. 65, no. 2, pp. 442–451,
2004.
[166] B. Bammens, P. Evenepoel, H. Keuleers, K. Verbeke, and Y. Vanrenterghem,
“Free serum concentrations of the protein-bound retention solute p-cresol predict
mortality in hemodialysis patients,” Kidney International, vol. 69, no. 6, pp. 1081–
1087, 2006.
[167] R. Vanholder, E. Schepers, A. Pletinck, E. Nagler, and G. Glorieux, “The uremic
toxicity of indoxyl sulfate and p-cresyl sulfate: a systematic review,” Journal of
the American Society of Nephrology, p. ASN. 2013101062, 2014.
[168] R. Foley, “Clinical epidemiology of cardiovascular disease in chronic kidney dis-
ease,” Journal of Renal Care, vol. 36, no. s1, pp. 4–8, 2010.
[169] F. Barreto, D. Barreto, S. Liabeuf, N. Meert, G. Glorieux, M. Temmar,
G. Choukroun, R. Vanholder, and Z. Massy, “Serum indoxyl sulfate is associated
with vascular disease and mortality in chronic kidney disease patients,” Clinical
Journal of the American Society of Nephrology, vol. 4, no. 10, pp. 1551–1558,
2009.
177
[170] S. Liabeuf, G. Glorieux, A. Lenglet, M. Diouf, E. Schepers, L. Desjardins,
R. Choukroun, G.and Vanholder, and Z. Massy, “Does p-cresylglucuronide have
the same impact on mortality as other protein-bound uremic toxins,” PLOS One,
vol. 8, no. 6, p. e67168, 2013.
[171] C. Herzog, “Dismal longterm survival of dialysis patients after acute myocar-
dial infarction: can we alter the outcome?,” Nephrology Dialysis Transplantation,
vol. 17, no. 1, pp. 7–10, 2002.
[172] R. Foley, P. Parfrey, and M. Sarnak, “Epidemiology of cardiovascular disease in
chronic renal disease,” Journal of the American Society of Nephrology, vol. 9,
no. 12 Suppl, pp. S16–23, 1998.
[173] T. W. Meyer, “The removal of protein-bound solutes by dialysis,” Journal of
Renal Nutrition, vol. 22, no. 1, pp. 203–206, 2012.






A.1 Adsorption of creatinine by various zeolites
During our experiments for this thesis, we tested 6 types of zeolite to adsorb creatinine.
In this section, we compare all of them through the following procedure.
The creatinine adsorption test was carried out as follow: 0.01 g zeolites were mea-
sured and added to tubes, and then 1 ml creatinine solution was added to these tubes
and incubated for 0.5 h. These tubes were centrifuged at 12000 rpm to precipitate the
zeolites. 500 µl supernatant was piped into 1.5 ml PBS buffer and mixed well before
ultraviolet spectrum tests.
The testing results are shown in Figure A.1. As we mentioned in the background,
the molecular size of creatinine is 0.71 x 0.81 x 0.3. Zeolites need to have comparable
pore channel size with creatinine in order to adsorb it. We can see that 720 type zeolite,
which is ferrite, barely adsorbs creatinine. The pore channel of ferrite is 0.42 x 0.54 and
0.35 x 0.48, which is smaller that the size of creatinine.
500-type zeolite does not adsorb any creatinine, even though the pore size is compa-
rable. The reason is that 500 is K+ cation type. H-protonated creatinine cannot replace
K+.
620, 640 and 690, which are H-morderite type zeolites, all adsorbed creatinine, but
in various levels. The relation between the adsorption levels was 640 = 690 > 620.
The pore channel sizes of H-morderite zeolites are 0.65 x 0.7 and 0.34 x 0.48, which are
comparable to that of creatinine. As H-morderite has H+ site in the channel, it can be
replace by H-protonated creatinine.
940, which is H-Beta type zeolite, adsorbed zeolite at the highest levels. Two reasons
contribute to this. The pore channel of this zeolite is 0.66 x 0.67 and 0.56 x 0.56 nm,
which is comparable to creatinine. 940 is H+ type zeolite and it have sites that can be
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Figure A.1: The adsorption of creatinine by zeolites.
replaced by protonated creatinine.
For the zeolites from ZSM group, the adsorption level of creatinine was P87 >
P371 = 890 > 840. This happens since P87 and P371 are nanoparticles; they have
smaller grain size and higher surface area. Therefore, their adsorption levels are higher
than that of microparticles (840,890).
A.2 Adsorption of uric acid by various zeolites
In some preliminaries experiments for this thesis, we tried to use zeolite to adsorb uric
acid. The results are shown in Figure A.2.
The uric acid adsorption test was carried out as follow: 0.01 g zeolites were measured
and added to tubes. Then, 1 ml uric acid with concentration of 0.2 mmol and 0.05 mmol
was added to these tubes and incubated for 0.5 h. These tubes were centrifuged at 12000
rpm to precipitate the zeolites. The supernatants were tested by ultraviolet spectrum
test. From the result we can see that 4 types of zeolite did not adsorb any uric acid.
A possible explanation is that the uric acid does not protonate, so they cannot replace
the adsorption site in zeolite. As such, zeolites do not adsorb uric acid.
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Figure A.2: The adsorption of uric acid by zeolites.
Name Structure Pore Size SiO2/AlO3 BET(m
2/g) Crystal size DLS
720 K-FER 0.42×0.54, 0.35×0.48 17.7 170 1000 4097
500 K-LTL 0.71×0.71 6 290 400 702.2
620 H-MOR 0.65×0.7,0.34×0.48 15.7 400 1000-3000 2106
640 H-MOR 0.65×0.7,0.34×0.48 18 380 100×500 1995
690 H-MOR 0.65×0.7,0.34×0.48 240 450 100×500 2315
940 H-Beta 0.66×0.67,0.56×0.56 40 530 500×1000 645
840 NH4-ZSM-5 0.51×0.55,0.53×0.56 40 330 2000×4000 1849
890 ZSM-5 0.51×0.55,0.53×0.56 1500 310 2000×5000 5560
P87 ZSM-5 0.51×0.55,0.53×0.56 87 362 300 578
P371 ZSM-5 0.51×0.55,0.53×0.56 371 362 300×700 687
Table A.1: Zeolites properties (all sizes in nm)
A.3 Zeolite comparison data
10 types of zeolites are purchased, with P87 and P371 from ACS Materials, LLC. and
the rest of them from Tosoh Corporation. Their properties incluing structure, pore size,
the ratio of SiO2/Al2O3, BET, crystal size and particles size mearused throuhg dynamic
light scattering are presented in Table A.1.
A.4 Creatinine standard
The creatinine standard is calculated by linear regressionA.3.
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Figure A.3: Creatinine standard
Figure A.4: Illustration of water flux testing system
A.5 Raw data for PES-zeolite
PES-zeolite adsorption raw data related to chapter 6 is presented in table. A.2
A.6 Water flux
The water flux of the spin-coated composite membranes was measured using a 10 ml
ultrafiltration cell from Millipore, the system is illustrated in Figure A.4. The effective
membrane area is 4.1 cm2. The system was first steadied with water for 20 min at 11
psi to compact the membranes. Then, the water flux was measured at 10 psi for 20 min,





where m is the quality of the permeated water (g); S is the effective membrane area
(m2); P is the pressure (hmmHg) and t is the permeated time (h).
The tested data is shown in Table A.3.
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Weight(g) Creatinine(mg/ml) Volume(ml) UV 235(nm)
0-PES 0.0348 0.1 6 1.371
0-PES 0.02998 0.1 6 1.339
0-PES 0.0334 0.1 6 1.368
50-840-PES 0.0822 0.1 6 0.439
50-840-PES 0.0794 0.1 6 0.375
50-840-PES 0.0767 0.1 6 0.59
50-P87-PES 0.1 0.1 6 0.784
50-P87-PES 0.104 0.1 6 0.738
50-P87-PES 0.097 0.1 6 0.828
50-P371-PES 0.1941 0.1 6 0.736
50-P371-PES 0.1797 0.1 6 0.924
50-P371-PES 0.1877 0.1 6 0.743
840 Powders 0.0406 0.1 6 0.8
840 Powders 0.0401 0.1 6 0.625
840 Powders 0.044 0.1 6 0.748
P87 Powders 0.05 0.1 6 0.445
P87 Powders 0.0513 0.1 6 0.485
P87 Powders 0.0505 0.1 6 0.439
P371 Powders 0.0919 0.1 6 0.224
P371 Powders 0.0906 0.1 6 0.224
P371 Powders 0.0925 0.1 6 0.184
Creatinine - 0.1 - 1.330
Creatinine - 0.1 - 1.369
Creatinine - 0.1 - 1.330
Table A.2: Creatinine adsorption by zeolites and their PES membranes.







Table A.3: Water flux
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Figure A.5: TGA data of pure PES and 50-P87-PES composite membranes
A.7 Thermal gravimetric analysis (TGA)
A Q500 TGA instrument from TA Instruments was used to carry out thermal gravimet-
ric analysis for pristine polyethersulfone and polyethersulfone-zeolite membranes. The
temperature scans were taken from room temperature to 800 ◦C with a heating rate of
10 ◦C min−1 and at an ambient atmosphere with a flow of 20 ml min−1. The results is
shown in Figure A.5.
A.8 Electric double layer for spherical particles
A sphere particle’s electric double layer is illustrated in Figure A.6. Debye length(λD)
is a measure of a charge charrier’s net electrostatic effect in solution, and it can be






where, I is the ionic strength of the electrolyte, and here the unit is mole/L, ǫ0 is the
permittivity of free space, ǫr is the dielectric constant, kB is the Boltzmann constant, T
is the absolute temperature in kelvins, NA is the Avogadro number, e is the elementary
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where, ci is the molar concentration of ion i (M, mol/L), zi is the charge number of that
ion.
We know that Debye length is proportionally related to ionic strength of solution





A.9 Adsorption raw data
PES-zeolite indoxyl sulfate adsoprtion raw data is presented in table. A.4
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Weight(g) IS(mg/100ml) Volume(ml) 0.5 h 1 h 3 h
0-PES 0.0347 3.5 6 471 561 480
0-PES 0.03348 3.5 6 535 563 511
0-PES 0.0329 3.5 6 495 555 536
50-P87-PES 0.102 3.5 6 392 417 357
50-P87-PES 0.0993 3.5 6 366 395 407
50-P87-PES 0.01026 3.5 6 368 418 401
P87 Powders 0.0572 3.5 6 367 341 366
P87 Powders 0.0569 3.5 6 386 373 380
P87 Powders 0.0506 3.5 6 399 385 396
- - 3.5 - 511
- - 3.5 - 504
- - 3.5 - 497
0-PES 0.0345 14 6 884 801 847
0-PES 0.03378 14 6 915 872 816
0-PES 0.0335 14 6 930 869 940
50-P87-PES 0.1013 14 6 808 789 814
50-P87-PES 0.1082 14 6 831 817 752
50-P87-PES 0.01023 14 6 844 795 877
P87 Powders 0.0534 14 6 787 767 797
P87 Powders 0.0526 14 6 786 781 797
P87 Powders 0.0563 14 6 796 776 813
- - 14 - 874
- - 14 - 881
- - 14 - 903
Table A.4: Indoxyl sulfate adsorption by P87 and its membranes.(EX 278 nm,EM 390 nm)
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